# pathway_nodes

date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,119
first_seen: 2022-12-05
last_seen: 2024-07-21
first_seen_parent: 2019-02-20
last_seen_parent: 2025-10-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 7.9 weekly interval (71.1 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 17 times with a 11.8 weekly interval (200.6 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 359.2, "avg_administrations": 5}, {"drug": "INFLIXIMAB", "avg_dose_mg": 282.4, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - DERMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £23,240
first_seen: 2021-04-11
last_seen: 2024-01-17
first_seen_parent: 2020-10-15
last_seen_parent: 2024-06-10
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 445.1, "avg_administrations": 27}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: DERMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 23 times with a 10.7 weekly interval (246.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,292
first_seen: 2020-06-22
last_seen: 2025-11-09
first_seen_parent: 2017-09-25
last_seen_parent: 2025-01-07
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 214.2, "avg_administrations": 4}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 4 times with a 2.6 weekly interval (10.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,600
first_seen: 2019-02-19
last_seen: 2024-01-29
first_seen_parent: 2017-08-22
last_seen_parent: 2024-01-24
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 221.7, "avg_administrations": 8}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 7.6 weekly interval (30.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,752
first_seen: 2020-11-07
last_seen: 2025-04-26
first_seen_parent: 2019-09-21
last_seen_parent: 2025-04-28
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 313.2, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 7.3 weekly interval (109.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £6,513
first_seen: 2022-05-08
last_seen: 2025-09-18
first_seen_parent: 2018-02-12
last_seen_parent: 2024-07-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 6 times with a 3.6 weekly interval (21.6 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 7.9 weekly interval (229.1 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 412.5, "avg_administrations": 28}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 287.1, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £8,057
first_seen: 2021-02-06
last_seen: 2025-10-20
first_seen_parent: 2020-04-04
last_seen_parent: 2025-01-31
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 2.9 weekly interval (20.3 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 18 times with a 11.2 weekly interval (201.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 230.7, "avg_administrations": 9}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 314.3, "avg_administrations": 19}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £16,513
first_seen: 2019-10-25
last_seen: 2025-03-05
first_seen_parent: 2018-07-05
last_seen_parent: 2025-08-03
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 467.9, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 26 times with a 4.3 weekly interval (111.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,458
first_seen: 2022-05-12
last_seen: 2024-02-04
first_seen_parent: 2018-08-12
last_seen_parent: 2024-06-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 29 times with a 7.1 weekly interval (205.9 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 28 times with a 11.7 weekly interval (327.6 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 457.2, "avg_administrations": 17}, {"drug": "NIVOLUMAB", "avg_dose_mg": 394.2, "avg_administrations": 11}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,216
first_seen: 2022-08-14
last_seen: 2024-05-25
first_seen_parent: 2018-11-21
last_seen_parent: 2024-08-12
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 22 times with a 4.0 weekly interval (88.0 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 24 times with a 8.6 weekly interval (206.4 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 371.1, "avg_administrations": 12}, {"drug": "INFLIXIMAB", "avg_dose_mg": 272.2, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,533
first_seen: 2020-12-08
last_seen: 2025-08-13
first_seen_parent: 2020-12-27
last_seen_parent: 2024-03-27
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 207.1, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 28 times with a 5.8 weekly interval (162.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £9,529
first_seen: 2018-04-25
last_seen: 2025-06-21
first_seen_parent: 2019-06-21
last_seen_parent: 2025-04-11
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 176.2, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 12 times with a 5.5 weekly interval (66.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,019
first_seen: 2019-06-25
last_seen: 2025-08-01
first_seen_parent: 2017-03-04
last_seen_parent: 2024-01-02
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 346.6, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 18 times with a 4.4 weekly interval (79.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £17,616
first_seen: 2022-06-23
last_seen: 2025-10-02
first_seen_parent: 2021-06-07
last_seen_parent: 2025-10-05
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 7.1 weekly interval (42.6 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 23 times with a 6.4 weekly interval (147.2 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 68.2, "avg_administrations": 16}, {"drug": "BARICITINIB", "avg_dose_mg": 416.2, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £5,243
first_seen: 2021-10-08
last_seen: 2024-10-18
first_seen_parent: 2020-02-05
last_seen_parent: 2024-11-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 26 times with a 9.2 weekly interval (239.2 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 23 times with a 9.9 weekly interval (227.7 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 490.2, "avg_administrations": 19}, {"drug": "USTEKINUMAB", "avg_dose_mg": 251.7, "avg_administrations": 10}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,852
first_seen: 2019-01-24
last_seen: 2025-08-06
first_seen_parent: 2018-09-20
last_seen_parent: 2025-08-06
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 189.1, "avg_administrations": 11}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 14 times with a 3.2 weekly interval (44.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,009
first_seen: 2019-01-14
last_seen: 2024-04-29
first_seen_parent: 2019-05-11
last_seen_parent: 2024-02-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 5.4 weekly interval (32.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 14 times with a 3.7 weekly interval (51.8 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 107.8, "avg_administrations": 19}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 386.4, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - BEVACIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,920
first_seen: 2022-02-15
last_seen: 2024-04-28
first_seen_parent: 2021-11-17
last_seen_parent: 2025-10-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 26 times with a 4.5 weekly interval (117.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 4 times with a 11.8 weekly interval (47.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 423.4, "avg_administrations": 9}, {"drug": "TOFACITINIB", "avg_dose_mg": 473.0, "avg_administrations": 26}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £12,493
first_seen: 2020-07-31
last_seen: 2024-01-25
first_seen_parent: 2019-07-29
last_seen_parent: 2025-03-16
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 175.7, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 9 times with a 7.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £3,630
first_seen: 2018-12-12
last_seen: 2025-04-29
first_seen_parent: 2018-08-28
last_seen_parent: 2024-10-19
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 448.2, "avg_administrations": 16}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 9 times with a 4.1 weekly interval (36.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,392
first_seen: 2020-11-10
last_seen: 2024-01-26
first_seen_parent: 2019-08-27
last_seen_parent: 2025-02-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 241.6, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 9.5 weekly interval (104.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,093
first_seen: 2021-10-01
last_seen: 2024-09-15
first_seen_parent: 2021-04-11
last_seen_parent: 2025-10-08
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 10 times with a 9.5 weekly interval (95.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 10 times with a 8.3 weekly interval (83.0 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 260.9, "avg_administrations": 6}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 455.1, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £18,762
first_seen: 2021-05-04
last_seen: 2025-09-09
first_seen_parent: 2018-09-14
last_seen_parent: 2024-03-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 29 times with a 11.5 weekly interval (333.5 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 12 times with a 9.6 weekly interval (115.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 431.7, "avg_administrations": 30}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 412.9, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,932
first_seen: 2021-04-07
last_seen: 2024-04-09
first_seen_parent: 2019-02-04
last_seen_parent: 2024-10-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 312.4, "avg_administrations": 18}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 4 times with a 7.0 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,710
first_seen: 2018-11-04
last_seen: 2024-11-29
first_seen_parent: 2018-02-12
last_seen_parent: 2024-09-05
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 352.1, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 15 times with a 2.1 weekly interval (31.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £11,387
first_seen: 2019-05-14
last_seen: 2024-05-15
first_seen_parent: 2021-06-23
last_seen_parent: 2025-02-22
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 16 times with a 2.3 weekly interval (36.8 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 13 times with a 10.5 weekly interval (136.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 409.6, "avg_administrations": 22}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 419.5, "avg_administrations": 11}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,847
first_seen: 2022-06-02
last_seen: 2025-01-20
first_seen_parent: 2019-08-08
last_seen_parent: 2024-11-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 11.3 weekly interval (158.2 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 12 times with a 2.3 weekly interval (27.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 290.4, "avg_administrations": 6}, {"drug": "USTEKINUMAB", "avg_dose_mg": 434.8, "avg_administrations": 11}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,908
first_seen: 2019-04-09
last_seen: 2025-08-07
first_seen_parent: 2020-07-16
last_seen_parent: 2025-10-23
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 336.9, "avg_administrations": 5}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 24 times with a 10.8 weekly interval (259.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £20,296
first_seen: 2020-01-10
last_seen: 2025-05-15
first_seen_parent: 2017-12-01
last_seen_parent: 2024-08-17
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 479.3, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 10 times with a 3.7 weekly interval (37.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £14,560
first_seen: 2018-07-14
last_seen: 2025-05-24
first_seen_parent: 2017-07-20
last_seen_parent: 2025-02-07
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 101.6, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 9 times with a 10.9 weekly interval (98.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £20,778
first_seen: 2018-09-18
last_seen: 2024-02-12
first_seen_parent: 2017-08-21
last_seen_parent: 2024-10-16
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 199.4, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 6.8 weekly interval (129.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,687
first_seen: 2019-11-16
last_seen: 2024-10-26
first_seen_parent: 2018-03-17
last_seen_parent: 2025-01-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 9.7 weekly interval (126.1 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 8.6 weekly interval (34.4 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 225.5, "avg_administrations": 13}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 91.0, "avg_administrations": 11}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £10,755
first_seen: 2020-03-29
last_seen: 2025-06-25
first_seen_parent: 2019-11-21
last_seen_parent: 2025-04-03
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 163.6, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 14 times with a 5.2 weekly interval (72.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £23,991
first_seen: 2021-09-04
last_seen: 2025-08-19
first_seen_parent: 2020-05-30
last_seen_parent: 2025-11-14
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 122.7, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 15 times with a 10.1 weekly interval (151.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - GASTROENTEROLOGY - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £18,753
first_seen: 2018-08-13
last_seen: 2025-11-13
first_seen_parent: 2020-12-12
last_seen_parent: 2024-03-22
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 223.4, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: GASTROENTEROLOGY
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 15 times with a 3.5 weekly interval (52.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £23,219
first_seen: 2020-11-22
last_seen: 2025-11-17
first_seen_parent: 2018-10-16
last_seen_parent: 2024-06-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 4 times with a 9.2 weekly interval (36.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 8.4 weekly interval (92.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 162.4, "avg_administrations": 13}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 399.4, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,851
first_seen: 2019-03-10
last_seen: 2025-05-23
first_seen_parent: 2019-04-19
last_seen_parent: 2024-10-30
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 304.4, "avg_administrations": 14}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 10.9 weekly interval (119.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,597
first_seen: 2019-01-11
last_seen: 2024-11-06
first_seen_parent: 2020-08-31
last_seen_parent: 2024-11-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 257.4, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 18 times with a 2.9 weekly interval (52.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,423
first_seen: 2020-08-01
last_seen: 2024-08-15
first_seen_parent: 2020-01-31
last_seen_parent: 2024-01-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 5 times with a 11.3 weekly interval (56.5 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 19 times with a 9.0 weekly interval (171.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 300.3, "avg_administrations": 12}, {"drug": "SECUKINUMAB", "avg_dose_mg": 457.5, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £16,767
first_seen: 2022-03-15
last_seen: 2024-02-24
first_seen_parent: 2021-01-03
last_seen_parent: 2025-03-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 9 times with a 8.8 weekly interval (79.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 10.2 weekly interval (40.8 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 290.7, "avg_administrations": 8}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 419.4, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £8,585
first_seen: 2018-01-22
last_seen: 2025-04-27
first_seen_parent: 2018-10-23
last_seen_parent: 2025-06-01
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 365.8, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 10 times with a 5.7 weekly interval (57.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £4,487
first_seen: 2018-12-27
last_seen: 2024-07-14
first_seen_parent: 2020-08-28
last_seen_parent: 2024-04-12
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 285.3, "avg_administrations": 13}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 7.6 weekly interval (68.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,188
first_seen: 2021-06-20
last_seen: 2024-10-13
first_seen_parent: 2019-10-30
last_seen_parent: 2024-10-06
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 13 times with a 6.9 weekly interval (89.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 5 times with a 7.2 weekly interval (36.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 174.4, "avg_administrations": 29}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 286.0, "avg_administrations": 21}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £15,234
first_seen: 2018-07-20
last_seen: 2024-06-23
first_seen_parent: 2018-10-18
last_seen_parent: 2024-06-19
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 155.6, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 5 times with a 7.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,422
first_seen: 2019-04-09
last_seen: 2024-06-15
first_seen_parent: 2019-06-01
last_seen_parent: 2025-01-03
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 271.5, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15 times with a 10.5 weekly interval (157.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £18,973
first_seen: 2019-08-08
last_seen: 2025-12-02
first_seen_parent: 2018-10-13
last_seen_parent: 2025-07-01
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 203.0, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 8.5 weekly interval (246.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,643
first_seen: 2019-03-04
last_seen: 2025-02-02
first_seen_parent: 2017-02-13
last_seen_parent: 2025-04-11
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 197.5, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 8.2 weekly interval (180.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,160
first_seen: 2021-03-30
last_seen: 2024-08-25
first_seen_parent: 2018-10-08
last_seen_parent: 2024-10-28
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 447.1, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14 times with a 6.0 weekly interval (84.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £25,315
first_seen: 2018-02-21
last_seen: 2025-08-04
first_seen_parent: 2019-05-25
last_seen_parent: 2024-12-09
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 245.3, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 7 times with a 2.3 weekly interval (16.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,542
first_seen: 2019-05-23
last_seen: 2025-09-23
first_seen_parent: 2019-02-20
last_seen_parent: 2025-02-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 8.3 weekly interval (149.4 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 25 times with a 9.4 weekly interval (235.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 432.3, "avg_administrations": 12}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 249.0, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £6,250
first_seen: 2019-08-27
last_seen: 2024-04-05
first_seen_parent: 2019-08-11
last_seen_parent: 2025-07-30
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 406.7, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 18 times with a 9.2 weekly interval (165.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,205
first_seen: 2018-07-17
last_seen: 2024-12-29
first_seen_parent: 2018-01-06
last_seen_parent: 2024-10-22
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 485.6, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 3.7 weekly interval (74.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,765
first_seen: 2020-02-15
last_seen: 2025-09-01
first_seen_parent: 2018-07-14
last_seen_parent: 2025-01-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5 times with a 4.7 weekly interval (23.5 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 6.0 weekly interval (162.0 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 282.3, "avg_administrations": 30}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 96.6, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £22,843
first_seen: 2021-11-02
last_seen: 2025-09-10
first_seen_parent: 2019-02-02
last_seen_parent: 2025-12-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5 times with a 10.1 weekly interval (50.5 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 15 times with a 5.7 weekly interval (85.5 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 475.9, "avg_administrations": 29}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 257.9, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,781
first_seen: 2021-01-13
last_seen: 2025-06-15
first_seen_parent: 2019-01-12
last_seen_parent: 2025-03-07
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 200.0, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 13 times with a 5.9 weekly interval (76.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £15,161
first_seen: 2020-12-26
last_seen: 2025-01-24
first_seen_parent: 2020-08-31
last_seen_parent: 2025-10-29
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 436.0, "avg_administrations": 25}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 25 times with a 3.9 weekly interval (97.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - DERMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £16,474
first_seen: 2021-06-19
last_seen: 2024-07-28
first_seen_parent: 2018-10-09
last_seen_parent: 2024-09-29
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 352.1, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: DERMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 5.2 weekly interval (98.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,889
first_seen: 2021-10-05
last_seen: 2024-11-13
first_seen_parent: 2018-12-12
last_seen_parent: 2024-08-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 8.1 weekly interval (170.1 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 8 times with a 12.0 weekly interval (96.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 165.9, "avg_administrations": 28}, {"drug": "USTEKINUMAB", "avg_dose_mg": 388.8, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,255
first_seen: 2022-01-26
last_seen: 2025-05-14
first_seen_parent: 2020-07-04
last_seen_parent: 2024-03-31
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20 times with a 3.7 weekly interval (74.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 30 times with a 10.6 weekly interval (318.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 273.3, "avg_administrations": 6}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 321.6, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £19,102
first_seen: 2020-02-16
last_seen: 2024-08-05
first_seen_parent: 2020-09-09
last_seen_parent: 2024-12-04
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 121.1, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 20 times with a 9.4 weekly interval (188.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £27,578
first_seen: 2019-01-04
last_seen: 2024-03-27
first_seen_parent: 2019-06-19
last_seen_parent: 2024-08-15
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 176.2, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8 times with a 3.9 weekly interval (31.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - GASTROENTEROLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £6,984
first_seen: 2020-10-03
last_seen: 2024-05-16
first_seen_parent: 2017-09-21
last_seen_parent: 2025-05-13
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 413.3, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: GASTROENTEROLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 13 times with a 9.6 weekly interval (124.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £2,900
first_seen: 2020-10-19
last_seen: 2024-09-18
first_seen_parent: 2018-05-21
last_seen_parent: 2025-05-29
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 11.2 weekly interval (56.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 5 times with a 11.6 weekly interval (58.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 493.8, "avg_administrations": 7}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 363.8, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,739
first_seen: 2022-09-23
last_seen: 2024-12-03
first_seen_parent: 2019-03-08
last_seen_parent: 2024-06-30
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 6 times with a 5.5 weekly interval (33.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 8 times with a 11.6 weekly interval (92.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 125.5, "avg_administrations": 19}, {"drug": "SECUKINUMAB", "avg_dose_mg": 333.9, "avg_administrations": 28}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,094
first_seen: 2020-09-27
last_seen: 2024-09-12
first_seen_parent: 2019-06-02
last_seen_parent: 2024-07-08
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 368.8, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 13 times with a 5.9 weekly interval (76.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £18,065
first_seen: 2019-12-24
last_seen: 2024-11-24
first_seen_parent: 2018-08-27
last_seen_parent: 2025-05-06
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 265.8, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 16 times with a 10.2 weekly interval (163.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HAEMATOLOGY - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £17,444
first_seen: 2018-04-01
last_seen: 2024-08-09
first_seen_parent: 2017-03-23
last_seen_parent: 2025-08-13
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 263.9, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: HAEMATOLOGY
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 16 times with a 11.2 weekly interval (179.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,680
first_seen: 2020-08-13
last_seen: 2024-12-20
first_seen_parent: 2021-08-02
last_seen_parent: 2025-02-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 30 times with a 9.3 weekly interval (279.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 11 times with a 6.6 weekly interval (72.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 377.1, "avg_administrations": 16}, {"drug": "RITUXIMAB", "avg_dose_mg": 454.6, "avg_administrations": 4}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,485
first_seen: 2021-02-17
last_seen: 2024-01-15
first_seen_parent: 2020-07-30
last_seen_parent: 2025-05-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 9 times with a 6.6 weekly interval (59.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 13 times with a 9.3 weekly interval (120.9 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 366.8, "avg_administrations": 9}, {"drug": "TOFACITINIB", "avg_dose_mg": 431.4, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £21,138
first_seen: 2019-04-06
last_seen: 2024-09-30
first_seen_parent: 2017-07-09
last_seen_parent: 2024-08-20
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 472.2, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 6.4 weekly interval (140.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,912
first_seen: 2021-11-19
last_seen: 2025-05-26
first_seen_parent: 2019-05-25
last_seen_parent: 2025-11-30
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 12 times with a 6.5 weekly interval (78.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 5 times with a 7.8 weekly interval (39.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 255.6, "avg_administrations": 14}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 330.5, "avg_administrations": 21}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,027
first_seen: 2021-03-22
last_seen: 2024-03-18
first_seen_parent: 2021-10-16
last_seen_parent: 2024-05-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 2.0 weekly interval (16.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 15 times with a 8.4 weekly interval (126.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 399.6, "avg_administrations": 16}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 263.8, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - NEUROLOGY - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,211
first_seen: 2019-05-31
last_seen: 2025-07-04
first_seen_parent: 2017-01-27
last_seen_parent: 2025-10-22
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 104.4, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: NEUROLOGY
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 23 times with a 3.1 weekly interval (71.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £6,667
first_seen: 2020-07-06
last_seen: 2024-04-25
first_seen_parent: 2017-09-02
last_seen_parent: 2025-04-04
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 101.7, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 7 times with a 10.1 weekly interval (70.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,410
first_seen: 2019-09-03
last_seen: 2025-02-23
first_seen_parent: 2017-05-01
last_seen_parent: 2024-12-21
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 180.5, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 11 times with a 2.1 weekly interval (23.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - ONCOLOGY - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,378
first_seen: 2021-09-08
last_seen: 2024-11-13
first_seen_parent: 2017-10-03
last_seen_parent: 2024-12-05
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 305.4, "avg_administrations": 8}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: ONCOLOGY
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 19 times with a 6.8 weekly interval (129.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £17,635
first_seen: 2022-08-07
last_seen: 2025-11-21
first_seen_parent: 2020-01-21
last_seen_parent: 2025-08-08
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 4.9 weekly interval (112.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 24 times with a 8.4 weekly interval (201.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 194.2, "avg_administrations": 18}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 405.6, "avg_administrations": 26}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £25,149
first_seen: 2019-11-12
last_seen: 2024-05-09
first_seen_parent: 2019-11-29
last_seen_parent: 2025-07-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 158.5, "avg_administrations": 27}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 8.0 weekly interval (216.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £3,712
first_seen: 2020-09-29
last_seen: 2025-10-11
first_seen_parent: 2020-08-20
last_seen_parent: 2024-06-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 23 times with a 6.0 weekly interval (138.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 6.4 weekly interval (51.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 51.4, "avg_administrations": 12}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 487.2, "avg_administrations": 28}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,073
first_seen: 2022-02-13
last_seen: 2025-06-22
first_seen_parent: 2021-01-02
last_seen_parent: 2024-05-27
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT|TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 18 times with a 7.1 weekly interval (127.8 weeks total treatment length)<br><b>TOCILIZUMAB</b><br>On average given 16 times with a 6.8 weekly interval (108.8 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 461.0, "avg_administrations": 12}, {"drug": "TOCILIZUMAB", "avg_dose_mg": 193.4, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £14,980
first_seen: 2018-12-18
last_seen: 2024-11-16
first_seen_parent: 2019-12-11
last_seen_parent: 2025-11-19
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 63.1, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 14 times with a 11.7 weekly interval (163.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - OPHTHALMOLOGY - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £23,224
first_seen: 2019-09-08
last_seen: 2025-06-24
first_seen_parent: 2020-09-01
last_seen_parent: 2024-04-23
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 308.4, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: OPHTHALMOLOGY
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 10.9 weekly interval (119.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,270
first_seen: 2019-02-25
last_seen: 2024-07-09
first_seen_parent: 2021-08-30
last_seen_parent: 2025-11-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 18 times with a 3.4 weekly interval (61.2 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 7 times with a 12.0 weekly interval (84.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 212.6, "avg_administrations": 21}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 376.3, "avg_administrations": 10}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £4,088
first_seen: 2022-07-06
last_seen: 2025-08-01
first_seen_parent: 2019-07-19
last_seen_parent: 2024-12-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 2.3 weekly interval (27.6 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 5 times with a 5.7 weekly interval (28.5 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 354.5, "avg_administrations": 17}, {"drug": "NATALIZUMAB", "avg_dose_mg": 252.3, "avg_administrations": 27}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,892
first_seen: 2018-10-17
last_seen: 2024-07-19
first_seen_parent: 2019-01-20
last_seen_parent: 2025-04-06
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 373.3, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 20 times with a 3.8 weekly interval (76.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £14,702
first_seen: 2022-10-20
last_seen: 2025-06-06
first_seen_parent: 2020-08-22
last_seen_parent: 2024-01-04
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 14 times with a 5.2 weekly interval (72.8 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 7 times with a 6.0 weekly interval (42.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 80.4, "avg_administrations": 6}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 69.7, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,947
first_seen: 2019-11-13
last_seen: 2025-05-06
first_seen_parent: 2019-08-29
last_seen_parent: 2025-08-13
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 56.7, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 3.3 weekly interval (39.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,628
first_seen: 2019-04-17
last_seen: 2025-12-21
first_seen_parent: 2019-09-17
last_seen_parent: 2024-05-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 4.5 weekly interval (130.5 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 11 times with a 11.3 weekly interval (124.3 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 485.8, "avg_administrations": 30}, {"drug": "INFLIXIMAB", "avg_dose_mg": 359.2, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,264
first_seen: 2022-08-11
last_seen: 2024-09-29
first_seen_parent: 2018-01-07
last_seen_parent: 2025-09-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 6.0 weekly interval (114.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 14 times with a 4.6 weekly interval (64.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 494.8, "avg_administrations": 27}, {"drug": "TOFACITINIB", "avg_dose_mg": 283.8, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,331
first_seen: 2020-03-03
last_seen: 2025-01-09
first_seen_parent: 2017-03-03
last_seen_parent: 2025-11-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 114.3, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 14 times with a 9.8 weekly interval (137.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £21,532
first_seen: 2021-01-02
last_seen: 2024-01-23
first_seen_parent: 2018-05-27
last_seen_parent: 2024-02-16
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 29 times with a 5.6 weekly interval (162.4 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 7.3 weekly interval (204.4 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 343.3, "avg_administrations": 21}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 114.0, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £14,805
first_seen: 2022-03-09
last_seen: 2025-05-18
first_seen_parent: 2019-08-27
last_seen_parent: 2025-11-06
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 10.8 weekly interval (43.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 22 times with a 7.6 weekly interval (167.2 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 327.5, "avg_administrations": 24}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 87.0, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,000
first_seen: 2018-04-10
last_seen: 2025-09-05
first_seen_parent: 2020-09-26
last_seen_parent: 2025-04-18
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 437.8, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15 times with a 7.5 weekly interval (112.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £8,290
first_seen: 2019-08-27
last_seen: 2025-01-22
first_seen_parent: 2018-12-21
last_seen_parent: 2024-09-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 20 times with a 10.6 weekly interval (212.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 3.8 weekly interval (60.8 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 291.0, "avg_administrations": 23}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 395.1, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £5,062
first_seen: 2019-08-27
last_seen: 2024-02-25
first_seen_parent: 2021-08-04
last_seen_parent: 2024-11-18
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 23 times with a 8.8 weekly interval (202.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 4 times with a 10.8 weekly interval (43.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 361.5, "avg_administrations": 9}, {"drug": "ADALIMUMAB", "avg_dose_mg": 57.9, "avg_administrations": 24}]


date_filter_id: 2yr_12mo
chart_type: directory
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - RHEUMATOLOGY - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £13,900
first_seen: 2018-05-13
last_seen: 2024-10-20
first_seen_parent: 2017-03-16
last_seen_parent: 2024-05-23
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 322.4, "avg_administrations": 7}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
directory: RHEUMATOLOGY
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 3.8 weekly interval (72.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £18,198
first_seen: 2020-01-13
last_seen: 2025-04-28
first_seen_parent: 2019-06-26
last_seen_parent: 2025-10-19
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 58.0, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 17 times with a 6.8 weekly interval (115.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,610
first_seen: 2021-03-01
last_seen: 2024-07-13
first_seen_parent: 2017-11-10
last_seen_parent: 2025-06-19
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 337.2, "avg_administrations": 27}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 18 times with a 9.5 weekly interval (171.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £7,708
first_seen: 2018-02-20
last_seen: 2024-06-29
first_seen_parent: 2019-09-14
last_seen_parent: 2024-09-08
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 265.1, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 29 times with a 8.7 weekly interval (252.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £12,866
first_seen: 2019-06-19
last_seen: 2024-08-21
first_seen_parent: 2017-05-16
last_seen_parent: 2024-04-04
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 374.7, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 7.7 weekly interval (107.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - CLL - IBRUTINIB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,661
first_seen: 2022-09-22
last_seen: 2024-12-03
first_seen_parent: 2020-09-05
last_seen_parent: 2024-11-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 14 times with a 8.0 weekly interval (112.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 24 times with a 10.3 weekly interval (247.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 140.6, "avg_administrations": 26}, {"drug": "USTEKINUMAB", "avg_dose_mg": 192.5, "avg_administrations": 22}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,363
first_seen: 2019-12-21
last_seen: 2024-01-13
first_seen_parent: 2017-10-08
last_seen_parent: 2024-09-01
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 154.2, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 30 times with a 6.0 weekly interval (180.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £24,577
first_seen: 2021-11-20
last_seen: 2025-07-26
first_seen_parent: 2019-05-17
last_seen_parent: 2024-02-06
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 491.8, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 30 times with a 8.0 weekly interval (240.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £9,237
first_seen: 2019-01-05
last_seen: 2024-06-09
first_seen_parent: 2017-05-15
last_seen_parent: 2024-04-23
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 176.3, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 18 times with a 2.7 weekly interval (48.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £25,961
first_seen: 2019-01-31
last_seen: 2024-11-27
first_seen_parent: 2020-05-23
last_seen_parent: 2024-01-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 386.5, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 4 times with a 11.9 weekly interval (47.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £9,922
first_seen: 2019-10-16
last_seen: 2024-02-02
first_seen_parent: 2017-07-10
last_seen_parent: 2025-10-27
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 341.4, "avg_administrations": 20}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 11 times with a 9.1 weekly interval (100.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £17,129
first_seen: 2021-11-17
last_seen: 2025-12-04
first_seen_parent: 2019-05-25
last_seen_parent: 2024-02-04
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 407.2, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 12 times with a 6.9 weekly interval (82.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £5,652
first_seen: 2021-02-21
last_seen: 2024-09-14
first_seen_parent: 2020-03-19
last_seen_parent: 2024-04-24
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 490.7, "avg_administrations": 28}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 29 times with a 4.4 weekly interval (127.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,032
first_seen: 2022-03-14
last_seen: 2024-06-01
first_seen_parent: 2020-04-15
last_seen_parent: 2025-05-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 9.5 weekly interval (209.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 14 times with a 3.1 weekly interval (43.4 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 360.3, "avg_administrations": 8}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 223.2, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,665
first_seen: 2020-05-23
last_seen: 2024-11-29
first_seen_parent: 2020-05-21
last_seen_parent: 2025-08-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 11 times with a 4.6 weekly interval (50.6 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 16 times with a 9.8 weekly interval (156.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 58.9, "avg_administrations": 29}, {"drug": "ETANERCEPT", "avg_dose_mg": 314.8, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £23,016
first_seen: 2018-05-22
last_seen: 2024-09-23
first_seen_parent: 2018-05-19
last_seen_parent: 2025-04-28
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 103.4, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 23 times with a 7.7 weekly interval (177.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £6,520
first_seen: 2021-03-27
last_seen: 2024-03-03
first_seen_parent: 2020-01-15
last_seen_parent: 2025-07-13
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 8 times with a 4.6 weekly interval (36.8 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 19 times with a 10.7 weekly interval (203.3 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 211.4, "avg_administrations": 13}, {"drug": "USTEKINUMAB", "avg_dose_mg": 275.2, "avg_administrations": 18}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,760
first_seen: 2021-02-16
last_seen: 2025-07-03
first_seen_parent: 2019-07-07
last_seen_parent: 2024-08-28
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 22 times with a 2.4 weekly interval (52.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 8 times with a 9.5 weekly interval (76.0 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 461.2, "avg_administrations": 12}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 187.7, "avg_administrations": 27}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £7,954
first_seen: 2021-02-21
last_seen: 2025-03-01
first_seen_parent: 2018-11-01
last_seen_parent: 2024-04-19
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 203.5, "avg_administrations": 6}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 10.2 weekly interval (193.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £15,839
first_seen: 2019-08-14
last_seen: 2025-03-28
first_seen_parent: 2018-06-10
last_seen_parent: 2025-04-27
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 489.5, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 14 times with a 9.0 weekly interval (126.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £13,540
first_seen: 2018-04-24
last_seen: 2025-03-08
first_seen_parent: 2020-01-07
last_seen_parent: 2024-11-28
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 365.0, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 15 times with a 11.1 weekly interval (166.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £5,429
first_seen: 2018-07-27
last_seen: 2025-09-19
first_seen_parent: 2017-04-14
last_seen_parent: 2024-03-10
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 478.3, "avg_administrations": 9}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 19 times with a 2.6 weekly interval (49.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,231
first_seen: 2020-10-29
last_seen: 2024-10-03
first_seen_parent: 2020-12-22
last_seen_parent: 2024-08-30
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 475.6, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 11 times with a 11.1 weekly interval (122.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £4,233
first_seen: 2019-09-06
last_seen: 2025-03-27
first_seen_parent: 2021-04-06
last_seen_parent: 2025-03-22
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - BEVACIZUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 6 times with a 10.8 weekly interval (64.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 11 times with a 6.7 weekly interval (73.7 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 211.6, "avg_administrations": 17}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 260.7, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: INFLIXIMAB
cost_pp_pa: £13,414
first_seen: 2021-09-16
last_seen: 2025-07-16
first_seen_parent: 2021-01-06
last_seen_parent: 2024-01-21
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: PEMBROLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - INFLIXIMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 28 times with a 3.2 weekly interval (89.6 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 6 times with a 9.1 weekly interval (54.6 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 295.9, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 391.6, "avg_administrations": 10}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,656
first_seen: 2019-12-29
last_seen: 2024-06-30
first_seen_parent: 2018-12-09
last_seen_parent: 2025-01-22
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 278.2, "avg_administrations": 18}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 25 times with a 6.8 weekly interval (170.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £14,442
first_seen: 2021-10-08
last_seen: 2024-12-26
first_seen_parent: 2019-02-21
last_seen_parent: 2024-05-03
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 230.3, "avg_administrations": 14}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 6 times with a 3.2 weekly interval (19.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £14,374
first_seen: 2020-02-03
last_seen: 2024-07-25
first_seen_parent: 2020-10-06
last_seen_parent: 2025-01-07
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 259.4, "avg_administrations": 16}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 23 times with a 6.9 weekly interval (158.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £7,743
first_seen: 2022-08-07
last_seen: 2024-01-09
first_seen_parent: 2020-06-04
last_seen_parent: 2025-07-14
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 9.1 weekly interval (182.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 30 times with a 7.7 weekly interval (231.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 116.3, "avg_administrations": 13}, {"drug": "NIVOLUMAB", "avg_dose_mg": 331.3, "avg_administrations": 10}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £12,480
first_seen: 2020-09-14
last_seen: 2025-10-13
first_seen_parent: 2021-05-10
last_seen_parent: 2024-04-27
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 20 times with a 3.9 weekly interval (78.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 18 times with a 5.5 weekly interval (99.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 201.7, "avg_administrations": 20}, {"drug": "TOFACITINIB", "avg_dose_mg": 108.8, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £25,922
first_seen: 2018-01-21
last_seen: 2024-06-06
first_seen_parent: 2018-12-23
last_seen_parent: 2025-06-20
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 450.9, "avg_administrations": 12}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 30 times with a 2.5 weekly interval (75.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £10,253
first_seen: 2021-07-24
last_seen: 2025-06-26
first_seen_parent: 2020-04-22
last_seen_parent: 2024-03-15
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 16 times with a 3.6 weekly interval (57.6 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 24 times with a 10.5 weekly interval (252.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 134.9, "avg_administrations": 9}, {"drug": "TOFACITINIB", "avg_dose_mg": 286.8, "avg_administrations": 19}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £10,910
first_seen: 2021-08-30
last_seen: 2025-04-02
first_seen_parent: 2019-04-13
last_seen_parent: 2024-09-15
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 267.8, "avg_administrations": 24}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 8 times with a 11.4 weekly interval (91.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £5,350
first_seen: 2020-01-28
last_seen: 2024-07-21
first_seen_parent: 2019-10-21
last_seen_parent: 2025-12-20
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 203.3, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 16 times with a 10.3 weekly interval (164.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,483
first_seen: 2019-12-26
last_seen: 2025-09-27
first_seen_parent: 2017-06-02
last_seen_parent: 2025-01-25
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 481.1, "avg_administrations": 5}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 5.0 weekly interval (35.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £27,990
first_seen: 2018-10-07
last_seen: 2025-08-31
first_seen_parent: 2019-03-30
last_seen_parent: 2025-11-30
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 192.3, "avg_administrations": 21}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 9.9 weekly interval (59.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - TOFACITINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £15,867
first_seen: 2020-01-24
last_seen: 2024-07-14
first_seen_parent: 2020-07-10
last_seen_parent: 2024-10-17
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 4.1 weekly interval (69.7 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 9 times with a 10.1 weekly interval (90.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 56.7, "avg_administrations": 17}, {"drug": "NIVOLUMAB", "avg_dose_mg": 83.7, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £17,402
first_seen: 2021-10-24
last_seen: 2024-12-26
first_seen_parent: 2019-11-09
last_seen_parent: 2024-09-07
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 95.1, "avg_administrations": 19}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 8 times with a 6.9 weekly interval (55.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £18,088
first_seen: 2019-10-18
last_seen: 2025-02-10
first_seen_parent: 2018-09-22
last_seen_parent: 2025-01-02
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 9.7 weekly interval (291.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 23 times with a 7.8 weekly interval (179.4 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 446.9, "avg_administrations": 24}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 427.7, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,399
first_seen: 2018-04-06
last_seen: 2025-12-01
first_seen_parent: 2020-08-16
last_seen_parent: 2025-07-04
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 283.7, "avg_administrations": 7}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 18 times with a 5.6 weekly interval (100.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £14,915
first_seen: 2021-09-17
last_seen: 2025-05-09
first_seen_parent: 2018-02-09
last_seen_parent: 2025-07-30
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20 times with a 9.3 weekly interval (186.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 12 times with a 9.3 weekly interval (111.6 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 233.5, "avg_administrations": 30}, {"drug": "TOFACITINIB", "avg_dose_mg": 221.6, "avg_administrations": 22}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £10,455
first_seen: 2020-01-02
last_seen: 2024-04-19
first_seen_parent: 2020-07-09
last_seen_parent: 2024-07-26
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 11 times with a 5.9 weekly interval (64.9 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 24 times with a 7.0 weekly interval (168.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 366.0, "avg_administrations": 11}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 76.6, "avg_administrations": 26}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £15,232
first_seen: 2021-10-13
last_seen: 2025-01-04
first_seen_parent: 2019-03-21
last_seen_parent: 2024-10-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 60.9, "avg_administrations": 13}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 9 times with a 10.3 weekly interval (92.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,099
first_seen: 2020-12-23
last_seen: 2024-04-23
first_seen_parent: 2019-08-06
last_seen_parent: 2024-07-30
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 142.3, "avg_administrations": 17}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 24 times with a 5.4 weekly interval (129.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,858
first_seen: 2020-06-06
last_seen: 2025-07-10
first_seen_parent: 2019-01-02
last_seen_parent: 2024-08-12
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 195.9, "avg_administrations": 25}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 24 times with a 9.5 weekly interval (228.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £7,976
first_seen: 2021-08-01
last_seen: 2025-10-08
first_seen_parent: 2017-09-10
last_seen_parent: 2025-04-21
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 215.5, "avg_administrations": 23}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 17 times with a 8.6 weekly interval (146.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,455
first_seen: 2021-05-09
last_seen: 2025-02-04
first_seen_parent: 2018-09-04
last_seen_parent: 2024-11-11
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 11.0 weekly interval (77.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 5 times with a 9.8 weekly interval (49.0 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 198.7, "avg_administrations": 14}, {"drug": "NATALIZUMAB", "avg_dose_mg": 156.7, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £16,818
first_seen: 2020-11-23
last_seen: 2025-10-04
first_seen_parent: 2021-12-26
last_seen_parent: 2025-02-19
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 28 times with a 6.6 weekly interval (184.8 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 5.5 weekly interval (38.5 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 168.2, "avg_administrations": 24}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 241.0, "avg_administrations": 4}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £10,997
first_seen: 2020-09-07
last_seen: 2024-08-28
first_seen_parent: 2017-04-08
last_seen_parent: 2025-02-06
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 453.8, "avg_administrations": 11}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 21 times with a 10.9 weekly interval (228.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £4,171
first_seen: 2022-04-16
last_seen: 2024-12-09
first_seen_parent: 2021-10-10
last_seen_parent: 2024-04-02
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 19 times with a 9.0 weekly interval (171.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 7 times with a 10.6 weekly interval (74.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 135.6, "avg_administrations": 26}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 400.5, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £17,090
first_seen: 2018-07-10
last_seen: 2024-05-30
first_seen_parent: 2019-05-03
last_seen_parent: 2024-12-12
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 351.9, "avg_administrations": 29}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5 times with a 3.5 weekly interval (17.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD
ids: DEMO ICS - GREENFIELD UNIVERSITY HOSPITAL NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £7,174
first_seen: 2020-11-23
last_seen: 2024-07-24
first_seen_parent: 2019-05-07
last_seen_parent: 2025-06-17
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 426.2, "avg_administrations": 15}]
trust_name: GREENFIELD UNIVERSITY HOSPITAL NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 27 times with a 10.6 weekly interval (286.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £20,706
first_seen: 2021-07-12
last_seen: 2025-09-06
first_seen_parent: 2020-03-25
last_seen_parent: 2025-01-21
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 81.4, "avg_administrations": 8}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 10 times with a 10.9 weekly interval (109.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,378
first_seen: 2022-07-31
last_seen: 2025-12-23
first_seen_parent: 2020-02-26
last_seen_parent: 2024-08-08
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 10.9 weekly interval (98.1 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 15 times with a 4.3 weekly interval (64.5 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 324.0, "avg_administrations": 29}, {"drug": "INFLIXIMAB", "avg_dose_mg": 296.2, "avg_administrations": 24}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £7,547
first_seen: 2019-08-20
last_seen: 2024-09-29
first_seen_parent: 2021-02-05
last_seen_parent: 2024-03-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 16 times with a 5.2 weekly interval (83.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 20 times with a 8.1 weekly interval (162.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 256.8, "avg_administrations": 18}, {"drug": "IBRUTINIB", "avg_dose_mg": 246.1, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £11,362
first_seen: 2018-01-29
last_seen: 2025-06-29
first_seen_parent: 2018-04-27
last_seen_parent: 2024-04-17
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 67.4, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 5.6 weekly interval (123.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £8,293
first_seen: 2022-12-18
last_seen: 2025-03-14
first_seen_parent: 2020-01-06
last_seen_parent: 2024-06-16
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 6 times with a 9.6 weekly interval (57.6 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 3.4 weekly interval (64.6 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 480.1, "avg_administrations": 12}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 254.2, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £9,739
first_seen: 2018-05-07
last_seen: 2024-03-16
first_seen_parent: 2020-12-15
last_seen_parent: 2025-01-25
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 246.2, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 29 times with a 5.4 weekly interval (156.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £21,606
first_seen: 2021-04-08
last_seen: 2024-09-01
first_seen_parent: 2018-08-26
last_seen_parent: 2025-02-10
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 67.7, "avg_administrations": 7}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 7.2 weekly interval (100.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £20,665
first_seen: 2018-12-22
last_seen: 2025-10-26
first_seen_parent: 2020-02-12
last_seen_parent: 2024-06-29
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 78.7, "avg_administrations": 19}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 2.8 weekly interval (22.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £5,763
first_seen: 2019-08-18
last_seen: 2025-07-26
first_seen_parent: 2020-05-31
last_seen_parent: 2025-11-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 12 times with a 5.9 weekly interval (70.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 7.5 weekly interval (97.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 291.8, "avg_administrations": 25}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 110.2, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £19,875
first_seen: 2021-06-01
last_seen: 2024-07-01
first_seen_parent: 2017-02-02
last_seen_parent: 2024-12-02
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 308.2, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 12 times with a 3.0 weekly interval (36.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £22,648
first_seen: 2018-05-18
last_seen: 2025-07-17
first_seen_parent: 2018-10-16
last_seen_parent: 2024-12-11
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 110.8, "avg_administrations": 5}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18 times with a 2.7 weekly interval (48.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,254
first_seen: 2021-06-07
last_seen: 2025-05-20
first_seen_parent: 2021-07-19
last_seen_parent: 2024-12-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 28 times with a 8.6 weekly interval (240.8 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 8 times with a 3.1 weekly interval (24.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 250.8, "avg_administrations": 11}, {"drug": "NIVOLUMAB", "avg_dose_mg": 142.8, "avg_administrations": 28}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - USTEKINUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,168
first_seen: 2020-01-07
last_seen: 2025-12-15
first_seen_parent: 2021-02-18
last_seen_parent: 2025-01-02
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 5 times with a 9.6 weekly interval (48.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 30 times with a 7.1 weekly interval (213.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 85.0, "avg_administrations": 21}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 417.7, "avg_administrations": 22}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,039
first_seen: 2020-05-27
last_seen: 2024-09-18
first_seen_parent: 2019-06-02
last_seen_parent: 2025-10-07
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 258.6, "avg_administrations": 30}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 8.4 weekly interval (226.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £15,575
first_seen: 2021-09-07
last_seen: 2024-07-18
first_seen_parent: 2020-12-20
last_seen_parent: 2024-04-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 15 times with a 7.0 weekly interval (105.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 7.6 weekly interval (129.2 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 453.8, "avg_administrations": 20}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 72.5, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £21,800
first_seen: 2021-12-10
last_seen: 2024-01-02
first_seen_parent: 2020-10-28
last_seen_parent: 2024-07-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 10.1 weekly interval (181.8 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 6.1 weekly interval (79.3 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 454.1, "avg_administrations": 16}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 318.9, "avg_administrations": 9}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £12,548
first_seen: 2020-09-22
last_seen: 2025-04-08
first_seen_parent: 2018-09-01
last_seen_parent: 2024-02-17
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 484.4, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 20 times with a 2.7 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £10,123
first_seen: 2018-08-12
last_seen: 2025-11-22
first_seen_parent: 2018-11-27
last_seen_parent: 2025-06-19
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 434.1, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 21 times with a 8.2 weekly interval (172.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £9,633
first_seen: 2019-07-03
last_seen: 2024-09-04
first_seen_parent: 2020-04-23
last_seen_parent: 2024-11-21
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 127.3, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 21 times with a 7.4 weekly interval (155.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £18,322
first_seen: 2022-12-20
last_seen: 2025-08-20
first_seen_parent: 2018-04-23
last_seen_parent: 2024-10-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 2.3 weekly interval (13.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 4.7 weekly interval (117.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 454.2, "avg_administrations": 22}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 430.9, "avg_administrations": 26}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £3,483
first_seen: 2020-07-07
last_seen: 2024-11-16
first_seen_parent: 2020-08-04
last_seen_parent: 2025-05-23
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 7 times with a 3.0 weekly interval (21.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 22 times with a 3.5 weekly interval (77.0 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 213.8, "avg_administrations": 22}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 421.9, "avg_administrations": 24}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £6,038
first_seen: 2020-11-12
last_seen: 2024-10-29
first_seen_parent: 2018-01-13
last_seen_parent: 2024-02-20
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 140.5, "avg_administrations": 11}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 6 times with a 4.1 weekly interval (24.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £28,007
first_seen: 2019-12-03
last_seen: 2025-01-20
first_seen_parent: 2018-12-23
last_seen_parent: 2024-11-26
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 366.6, "avg_administrations": 28}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 9 times with a 4.4 weekly interval (39.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £11,574
first_seen: 2021-11-29
last_seen: 2025-11-20
first_seen_parent: 2019-07-14
last_seen_parent: 2024-12-17
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 266.1, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 13 times with a 9.1 weekly interval (118.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £23,862
first_seen: 2019-12-07
last_seen: 2024-06-17
first_seen_parent: 2019-02-08
last_seen_parent: 2024-08-03
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 129.6, "avg_administrations": 21}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 27 times with a 11.8 weekly interval (318.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £3,466
first_seen: 2020-06-17
last_seen: 2024-11-27
first_seen_parent: 2020-11-19
last_seen_parent: 2024-01-22
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 10.7 weekly interval (64.2 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 2.1 weekly interval (42.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 326.4, "avg_administrations": 5}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 314.3, "avg_administrations": 28}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,011
first_seen: 2020-11-30
last_seen: 2024-10-25
first_seen_parent: 2020-03-28
last_seen_parent: 2024-10-19
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 20 times with a 4.6 weekly interval (92.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 11 times with a 10.2 weekly interval (112.2 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 498.7, "avg_administrations": 5}, {"drug": "RITUXIMAB", "avg_dose_mg": 477.5, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,832
first_seen: 2019-07-03
last_seen: 2024-08-04
first_seen_parent: 2017-03-12
last_seen_parent: 2024-08-01
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 261.4, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 8 times with a 2.6 weekly interval (20.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £3,331
first_seen: 2019-06-12
last_seen: 2025-02-11
first_seen_parent: 2020-11-11
last_seen_parent: 2024-07-17
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 8 times with a 6.4 weekly interval (51.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 15 times with a 5.0 weekly interval (75.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 376.2, "avg_administrations": 19}, {"drug": "IBRUTINIB", "avg_dose_mg": 143.3, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £18,871
first_seen: 2019-05-21
last_seen: 2024-11-01
first_seen_parent: 2018-02-25
last_seen_parent: 2024-06-26
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 358.3, "avg_administrations": 20}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 4 times with a 7.0 weekly interval (28.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £9,241
first_seen: 2021-12-31
last_seen: 2024-03-23
first_seen_parent: 2020-03-18
last_seen_parent: 2024-01-01
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 25 times with a 6.6 weekly interval (165.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 22 times with a 9.7 weekly interval (213.4 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 79.6, "avg_administrations": 10}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 413.6, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £14,603
first_seen: 2021-10-04
last_seen: 2024-05-04
first_seen_parent: 2020-09-19
last_seen_parent: 2025-09-04
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 57.7, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 22 times with a 2.5 weekly interval (55.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: NIVOLUMAB
cost_pp_pa: £13,326
first_seen: 2022-06-30
last_seen: 2025-10-02
first_seen_parent: 2019-08-09
last_seen_parent: 2025-04-21
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB - NIVOLUMAB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 11 times with a 7.5 weekly interval (82.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 17 times with a 9.5 weekly interval (161.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 393.4, "avg_administrations": 17}, {"drug": "NIVOLUMAB", "avg_dose_mg": 219.3, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £19,361
first_seen: 2018-02-08
last_seen: 2024-07-23
first_seen_parent: 2020-02-20
last_seen_parent: 2025-03-16
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 94.9, "avg_administrations": 4}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 19 times with a 3.9 weekly interval (74.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,677
first_seen: 2022-03-27
last_seen: 2024-09-30
first_seen_parent: 2021-11-11
last_seen_parent: 2024-08-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - ADALIMUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 7.9 weekly interval (47.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 27 times with a 10.3 weekly interval (278.1 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 73.9, "avg_administrations": 17}, {"drug": "ADALIMUMAB", "avg_dose_mg": 185.0, "avg_administrations": 18}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £5,687
first_seen: 2021-10-16
last_seen: 2024-01-25
first_seen_parent: 2017-05-07
last_seen_parent: 2024-04-18
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 390.7, "avg_administrations": 10}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 10.3 weekly interval (61.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £7,378
first_seen: 2021-10-23
last_seen: 2024-05-18
first_seen_parent: 2018-04-05
last_seen_parent: 2024-08-18
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - OCRELIZUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 16 times with a 7.5 weekly interval (120.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 12 times with a 6.1 weekly interval (73.2 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 286.4, "avg_administrations": 11}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 333.6, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £5,927
first_seen: 2019-02-07
last_seen: 2025-08-05
first_seen_parent: 2020-07-23
last_seen_parent: 2025-11-30
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 62.3, "avg_administrations": 16}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 18 times with a 5.1 weekly interval (91.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £11,256
first_seen: 2021-03-07
last_seen: 2024-03-05
first_seen_parent: 2020-11-28
last_seen_parent: 2024-07-10
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 383.3, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 26 times with a 5.6 weekly interval (145.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,282
first_seen: 2018-08-07
last_seen: 2025-03-21
first_seen_parent: 2020-12-09
last_seen_parent: 2025-02-25
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 321.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 11.5 weekly interval (115.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £16,730
first_seen: 2019-05-13
last_seen: 2024-03-30
first_seen_parent: 2019-02-25
last_seen_parent: 2024-05-19
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 133.7, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 19 times with a 3.0 weekly interval (57.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,198
first_seen: 2021-08-04
last_seen: 2024-01-09
first_seen_parent: 2018-11-18
last_seen_parent: 2024-01-15
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 19 times with a 5.3 weekly interval (100.7 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 19 times with a 9.2 weekly interval (174.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 309.1, "avg_administrations": 11}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 395.0, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £9,411
first_seen: 2021-08-03
last_seen: 2024-11-22
first_seen_parent: 2017-06-30
last_seen_parent: 2024-07-17
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 234.3, "avg_administrations": 12}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 8.0 weekly interval (64.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,914
first_seen: 2019-04-23
last_seen: 2025-11-02
first_seen_parent: 2017-05-13
last_seen_parent: 2024-01-17
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 378.7, "avg_administrations": 22}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 8.6 weekly interval (60.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £12,621
first_seen: 2018-06-28
last_seen: 2025-02-26
first_seen_parent: 2018-11-13
last_seen_parent: 2025-10-27
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 407.1, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 11 times with a 3.4 weekly interval (37.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,862
first_seen: 2020-08-08
last_seen: 2024-07-17
first_seen_parent: 2020-02-15
last_seen_parent: 2025-07-11
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 17 times with a 5.3 weekly interval (90.1 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 27 times with a 6.6 weekly interval (178.2 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 70.3, "avg_administrations": 9}, {"drug": "INFLIXIMAB", "avg_dose_mg": 266.6, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £22,223
first_seen: 2020-06-16
last_seen: 2024-08-25
first_seen_parent: 2017-01-11
last_seen_parent: 2025-05-21
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 397.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,215
first_seen: 2019-07-13
last_seen: 2024-11-03
first_seen_parent: 2020-07-02
last_seen_parent: 2024-09-07
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 63.0, "avg_administrations": 15}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 6.5 weekly interval (195.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £18,169
first_seen: 2019-04-04
last_seen: 2024-10-14
first_seen_parent: 2019-01-23
last_seen_parent: 2025-04-02
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 238.9, "avg_administrations": 29}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 16 times with a 6.3 weekly interval (100.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,040
first_seen: 2020-04-12
last_seen: 2024-02-29
first_seen_parent: 2019-12-27
last_seen_parent: 2024-06-17
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 4.1 weekly interval (49.2 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 29 times with a 4.3 weekly interval (124.7 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 389.3, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 228.2, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £13,907
first_seen: 2022-07-24
last_seen: 2024-01-29
first_seen_parent: 2021-06-29
last_seen_parent: 2024-08-24
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 17 times with a 10.8 weekly interval (183.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 22 times with a 5.9 weekly interval (129.8 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 158.2, "avg_administrations": 25}, {"drug": "IBRUTINIB", "avg_dose_mg": 373.3, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,541
first_seen: 2020-02-20
last_seen: 2025-01-18
first_seen_parent: 2019-07-17
last_seen_parent: 2024-07-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 211.6, "avg_administrations": 14}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 3.1 weekly interval (37.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,803
first_seen: 2022-01-08
last_seen: 2024-09-22
first_seen_parent: 2018-06-28
last_seen_parent: 2025-07-04
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 19 times with a 9.6 weekly interval (182.4 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 7 times with a 4.6 weekly interval (32.2 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 68.6, "avg_administrations": 30}, {"drug": "TOFACITINIB", "avg_dose_mg": 469.7, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £16,491
first_seen: 2020-02-24
last_seen: 2025-02-08
first_seen_parent: 2018-01-09
last_seen_parent: 2024-05-09
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 11.8 weekly interval (82.6 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 21 times with a 2.1 weekly interval (44.1 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 272.7, "avg_administrations": 6}, {"drug": "BARICITINIB", "avg_dose_mg": 495.1, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,986
first_seen: 2018-01-14
last_seen: 2025-05-13
first_seen_parent: 2017-10-16
last_seen_parent: 2024-03-14
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 167.8, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 12 times with a 10.0 weekly interval (120.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £20,597
first_seen: 2021-01-20
last_seen: 2024-09-03
first_seen_parent: 2017-10-15
last_seen_parent: 2025-02-08
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 305.2, "avg_administrations": 23}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 16 times with a 9.3 weekly interval (148.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £2,744
first_seen: 2020-12-03
last_seen: 2024-03-26
first_seen_parent: 2017-12-09
last_seen_parent: 2024-07-15
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 200.2, "avg_administrations": 24}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 9 times with a 6.1 weekly interval (54.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Uveitis - ADALIMUMAB - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £17,281
first_seen: 2021-02-13
last_seen: 2024-03-31
first_seen_parent: 2020-07-05
last_seen_parent: 2025-03-07
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: ADALIMUMAB|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 7 times with a 11.0 weekly interval (77.0 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 11 times with a 9.3 weekly interval (102.3 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 236.0, "avg_administrations": 23}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 461.0, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £15,783
first_seen: 2021-08-01
last_seen: 2025-01-15
first_seen_parent: 2020-09-03
last_seen_parent: 2024-01-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 128.7, "avg_administrations": 18}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 6.5 weekly interval (195.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD
ids: DEMO ICS - RIVERSIDE DISTRICT GENERAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £15,969
first_seen: 2021-05-09
last_seen: 2024-12-10
first_seen_parent: 2018-01-21
last_seen_parent: 2025-02-05
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 346.3, "avg_administrations": 25}]
trust_name: RIVERSIDE DISTRICT GENERAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 10 times with a 5.1 weekly interval (51.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £22,206
first_seen: 2021-09-06
last_seen: 2024-03-20
first_seen_parent: 2017-08-07
last_seen_parent: 2024-06-08
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 300.2, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 8 times with a 8.3 weekly interval (66.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £20,898
first_seen: 2022-08-18
last_seen: 2025-02-14
first_seen_parent: 2021-08-22
last_seen_parent: 2024-03-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 15 times with a 8.0 weekly interval (120.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 26 times with a 5.6 weekly interval (145.6 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 399.4, "avg_administrations": 27}, {"drug": "ETANERCEPT", "avg_dose_mg": 184.0, "avg_administrations": 4}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £14,059
first_seen: 2020-01-10
last_seen: 2024-05-13
first_seen_parent: 2017-10-05
last_seen_parent: 2024-03-23
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 63.5, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 7 times with a 7.5 weekly interval (52.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £13,177
first_seen: 2018-11-14
last_seen: 2024-12-20
first_seen_parent: 2017-02-12
last_seen_parent: 2024-04-07
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 201.9, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 27 times with a 10.6 weekly interval (286.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £4,909
first_seen: 2019-11-03
last_seen: 2025-04-13
first_seen_parent: 2020-07-12
last_seen_parent: 2024-04-24
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 430.7, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 9 times with a 5.6 weekly interval (50.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,829
first_seen: 2021-05-06
last_seen: 2024-12-21
first_seen_parent: 2019-10-04
last_seen_parent: 2025-10-11
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 299.5, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 2.4 weekly interval (52.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £8,313
first_seen: 2019-01-20
last_seen: 2024-05-14
first_seen_parent: 2020-07-04
last_seen_parent: 2024-11-03
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 483.6, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 17 times with a 6.8 weekly interval (115.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £12,553
first_seen: 2021-03-26
last_seen: 2025-02-03
first_seen_parent: 2019-04-03
last_seen_parent: 2024-10-06
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 9 times with a 11.9 weekly interval (107.1 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 13 times with a 2.3 weekly interval (29.9 weeks total treatment length)

average_administered:
[{"drug": "INFLIXIMAB", "avg_dose_mg": 353.3, "avg_administrations": 29}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 96.8, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £12,886
first_seen: 2018-04-22
last_seen: 2025-01-18
first_seen_parent: 2020-07-30
last_seen_parent: 2025-08-12
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 373.0, "avg_administrations": 25}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 17 times with a 4.5 weekly interval (76.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £15,962
first_seen: 2019-10-15
last_seen: 2024-10-21
first_seen_parent: 2020-07-09
last_seen_parent: 2025-11-02
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 419.0, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 29 times with a 6.6 weekly interval (191.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,488
first_seen: 2020-08-26
last_seen: 2024-05-16
first_seen_parent: 2018-11-11
last_seen_parent: 2025-05-20
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 24 times with a 5.0 weekly interval (120.0 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 9 times with a 3.6 weekly interval (32.4 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 484.4, "avg_administrations": 12}, {"drug": "NIVOLUMAB", "avg_dose_mg": 50.4, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £24,509
first_seen: 2018-08-12
last_seen: 2024-06-22
first_seen_parent: 2020-03-19
last_seen_parent: 2024-01-06
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 424.7, "avg_administrations": 24}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 20 times with a 6.8 weekly interval (136.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £10,917
first_seen: 2018-10-09
last_seen: 2025-06-16
first_seen_parent: 2018-05-29
last_seen_parent: 2024-05-08
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 164.7, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 29 times with a 2.9 weekly interval (84.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £17,183
first_seen: 2022-12-26
last_seen: 2025-04-17
first_seen_parent: 2020-02-04
last_seen_parent: 2025-07-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 10 times with a 8.1 weekly interval (81.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 11 times with a 9.5 weekly interval (104.5 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 240.6, "avg_administrations": 9}, {"drug": "SECUKINUMAB", "avg_dose_mg": 475.7, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £19,574
first_seen: 2019-10-18
last_seen: 2025-03-30
first_seen_parent: 2018-05-11
last_seen_parent: 2025-02-18
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 28 times with a 7.3 weekly interval (204.4 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 18 times with a 5.7 weekly interval (102.6 weeks total treatment length)

average_administered:
[{"drug": "TRASTUZUMAB", "avg_dose_mg": 444.3, "avg_administrations": 20}, {"drug": "ETANERCEPT", "avg_dose_mg": 313.2, "avg_administrations": 28}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £14,513
first_seen: 2021-03-05
last_seen: 2024-07-30
first_seen_parent: 2020-03-09
last_seen_parent: 2025-08-06
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 144.1, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 4 times with a 6.1 weekly interval (24.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £16,684
first_seen: 2020-07-26
last_seen: 2024-06-28
first_seen_parent: 2019-09-17
last_seen_parent: 2025-04-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB|TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 7 times with a 10.0 weekly interval (70.0 weeks total treatment length)<br><b>TOFACITINIB</b><br>On average given 20 times with a 9.1 weekly interval (182.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 316.9, "avg_administrations": 14}, {"drug": "TOFACITINIB", "avg_dose_mg": 183.4, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £9,045
first_seen: 2020-11-10
last_seen: 2025-05-30
first_seen_parent: 2020-07-10
last_seen_parent: 2025-11-04
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 52.4, "avg_administrations": 10}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 9 times with a 3.4 weekly interval (30.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £11,742
first_seen: 2022-04-23
last_seen: 2025-04-23
first_seen_parent: 2019-11-24
last_seen_parent: 2024-10-02
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 12 times with a 3.6 weekly interval (43.2 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 5 times with a 10.5 weekly interval (52.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 228.8, "avg_administrations": 18}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 281.9, "avg_administrations": 16}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £16,061
first_seen: 2021-02-11
last_seen: 2025-09-11
first_seen_parent: 2021-12-02
last_seen_parent: 2025-01-10
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 23 times with a 3.3 weekly interval (75.9 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 13 times with a 10.7 weekly interval (139.1 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 481.6, "avg_administrations": 8}, {"drug": "SECUKINUMAB", "avg_dose_mg": 351.0, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,981
first_seen: 2019-08-28
last_seen: 2025-09-18
first_seen_parent: 2019-06-18
last_seen_parent: 2025-01-15
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 304.6, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 8 times with a 10.9 weekly interval (87.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £8,637
first_seen: 2021-09-16
last_seen: 2024-07-13
first_seen_parent: 2021-12-25
last_seen_parent: 2025-03-07
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 15 times with a 8.3 weekly interval (124.5 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 12 times with a 3.7 weekly interval (44.4 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 420.0, "avg_administrations": 21}, {"drug": "NATALIZUMAB", "avg_dose_mg": 185.1, "avg_administrations": 16}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £15,516
first_seen: 2019-07-30
last_seen: 2024-01-03
first_seen_parent: 2021-01-25
last_seen_parent: 2025-09-03
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 28 times with a 7.7 weekly interval (215.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 4.0 weekly interval (52.0 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 310.8, "avg_administrations": 13}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 458.8, "avg_administrations": 11}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £20,263
first_seen: 2018-03-25
last_seen: 2024-10-30
first_seen_parent: 2020-04-01
last_seen_parent: 2025-12-10
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 250.5, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 17 times with a 5.2 weekly interval (88.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £17,454
first_seen: 2019-01-26
last_seen: 2024-06-23
first_seen_parent: 2018-05-26
last_seen_parent: 2024-11-11
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 6 times with a 9.2 weekly interval (55.2 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 10.6 weekly interval (106.0 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 174.7, "avg_administrations": 4}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 60.1, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £6,446
first_seen: 2019-12-06
last_seen: 2024-12-04
first_seen_parent: 2020-07-04
last_seen_parent: 2024-03-19
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 22 times with a 3.5 weekly interval (77.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 26 times with a 5.6 weekly interval (145.6 weeks total treatment length)

average_administered:
[{"drug": "OCRELIZUMAB", "avg_dose_mg": 483.1, "avg_administrations": 8}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 276.7, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £10,805
first_seen: 2019-05-30
last_seen: 2025-06-28
first_seen_parent: 2018-02-28
last_seen_parent: 2024-10-04
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 366.3, "avg_administrations": 7}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 13 times with a 5.0 weekly interval (65.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £19,675
first_seen: 2018-02-25
last_seen: 2025-06-23
first_seen_parent: 2019-01-17
last_seen_parent: 2024-08-10
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 226.6, "avg_administrations": 30}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 7.4 weekly interval (66.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £4,757
first_seen: 2018-11-30
last_seen: 2024-12-17
first_seen_parent: 2019-09-26
last_seen_parent: 2025-09-02
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 488.4, "avg_administrations": 13}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 28 times with a 2.8 weekly interval (78.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £8,480
first_seen: 2020-04-10
last_seen: 2025-06-15
first_seen_parent: 2020-08-07
last_seen_parent: 2025-12-21
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 75.4, "avg_administrations": 17}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 21 times with a 11.1 weekly interval (233.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £20,442
first_seen: 2020-04-16
last_seen: 2025-05-26
first_seen_parent: 2020-07-04
last_seen_parent: 2024-12-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 303.2, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 27 times with a 3.9 weekly interval (105.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £10,737
first_seen: 2020-10-05
last_seen: 2024-01-05
first_seen_parent: 2020-08-14
last_seen_parent: 2024-04-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 9.7 weekly interval (126.1 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 23 times with a 4.6 weekly interval (105.8 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 50.2, "avg_administrations": 4}, {"drug": "ETANERCEPT", "avg_dose_mg": 391.9, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,189
first_seen: 2020-04-10
last_seen: 2024-05-01
first_seen_parent: 2020-03-18
last_seen_parent: 2024-02-17
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 4 times with a 2.3 weekly interval (9.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 11 times with a 11.5 weekly interval (126.5 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 145.0, "avg_administrations": 25}, {"drug": "IBRUTINIB", "avg_dose_mg": 365.0, "avg_administrations": 9}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £18,748
first_seen: 2019-12-01
last_seen: 2025-05-01
first_seen_parent: 2020-02-09
last_seen_parent: 2025-03-30
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 120.5, "avg_administrations": 14}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 19 times with a 2.6 weekly interval (49.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £2,868
first_seen: 2019-02-27
last_seen: 2024-11-28
first_seen_parent: 2018-01-26
last_seen_parent: 2024-01-30
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 164.6, "avg_administrations": 15}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 9 times with a 6.8 weekly interval (61.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £19,654
first_seen: 2019-07-08
last_seen: 2024-06-19
first_seen_parent: 2019-08-14
last_seen_parent: 2024-08-04
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 24 times with a 9.9 weekly interval (237.6 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 9 times with a 7.0 weekly interval (63.0 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 420.9, "avg_administrations": 7}, {"drug": "IBRUTINIB", "avg_dose_mg": 359.1, "avg_administrations": 18}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriasis - USTEKINUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £22,517
first_seen: 2021-11-03
last_seen: 2024-03-19
first_seen_parent: 2019-02-27
last_seen_parent: 2025-02-25
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: USTEKINUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 21 times with a 6.6 weekly interval (138.6 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 29 times with a 7.4 weekly interval (214.6 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 101.6, "avg_administrations": 8}, {"drug": "ADALIMUMAB", "avg_dose_mg": 262.5, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £3,602
first_seen: 2019-05-28
last_seen: 2025-08-10
first_seen_parent: 2018-01-07
last_seen_parent: 2025-07-21
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 20 times with a 10.9 weekly interval (218.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 21 times with a 6.8 weekly interval (142.8 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 282.0, "avg_administrations": 13}, {"drug": "ADALIMUMAB", "avg_dose_mg": 326.4, "avg_administrations": 28}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £16,608
first_seen: 2022-03-31
last_seen: 2024-07-25
first_seen_parent: 2019-02-23
last_seen_parent: 2025-02-15
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 29 times with a 4.1 weekly interval (118.9 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 10 times with a 6.8 weekly interval (68.0 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 380.0, "avg_administrations": 4}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 207.5, "avg_administrations": 16}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,578
first_seen: 2018-03-13
last_seen: 2025-12-13
first_seen_parent: 2017-08-04
last_seen_parent: 2024-02-04
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 256.1, "avg_administrations": 28}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 12 times with a 6.7 weekly interval (80.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £12,534
first_seen: 2021-10-10
last_seen: 2025-11-19
first_seen_parent: 2020-08-04
last_seen_parent: 2024-05-16
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 489.6, "avg_administrations": 19}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 4 times with a 5.5 weekly interval (22.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £13,073
first_seen: 2020-05-24
last_seen: 2025-09-20
first_seen_parent: 2019-08-22
last_seen_parent: 2024-02-08
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 18 times with a 7.0 weekly interval (126.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 9 times with a 7.8 weekly interval (70.2 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 307.0, "avg_administrations": 16}, {"drug": "ADALIMUMAB", "avg_dose_mg": 136.7, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £12,398
first_seen: 2022-12-13
last_seen: 2025-10-04
first_seen_parent: 2018-04-26
last_seen_parent: 2025-02-11
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 7.1 weekly interval (120.7 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 24 times with a 10.0 weekly interval (240.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 290.7, "avg_administrations": 27}, {"drug": "IBRUTINIB", "avg_dose_mg": 288.7, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £10,660
first_seen: 2020-06-29
last_seen: 2025-07-19
first_seen_parent: 2018-07-02
last_seen_parent: 2025-11-11
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 261.7, "avg_administrations": 22}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 14 times with a 8.2 weekly interval (114.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,677
first_seen: 2020-04-03
last_seen: 2025-01-10
first_seen_parent: 2019-06-26
last_seen_parent: 2024-06-24
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 15 times with a 3.9 weekly interval (58.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 14 times with a 4.9 weekly interval (68.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 330.1, "avg_administrations": 30}, {"drug": "NIVOLUMAB", "avg_dose_mg": 331.3, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £11,483
first_seen: 2020-11-24
last_seen: 2025-11-10
first_seen_parent: 2018-01-18
last_seen_parent: 2024-09-13
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 9.5 weekly interval (133.0 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 20 times with a 2.5 weekly interval (50.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 228.8, "avg_administrations": 12}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 238.2, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,190
first_seen: 2020-08-16
last_seen: 2024-08-20
first_seen_parent: 2018-07-06
last_seen_parent: 2025-02-23
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 479.7, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 5.3 weekly interval (159.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £6,008
first_seen: 2019-11-18
last_seen: 2025-01-10
first_seen_parent: 2018-04-03
last_seen_parent: 2024-12-03
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 78.9, "avg_administrations": 12}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 30 times with a 6.1 weekly interval (183.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £6,531
first_seen: 2020-07-02
last_seen: 2024-01-17
first_seen_parent: 2017-08-13
last_seen_parent: 2025-10-07
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 128.6, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 27 times with a 3.5 weekly interval (94.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ETANERCEPT
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Rheumatoid arthritis - ETANERCEPT - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £3,813
first_seen: 2019-03-15
last_seen: 2025-05-31
first_seen_parent: 2018-10-25
last_seen_parent: 2025-04-23
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ETANERCEPT|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 30 times with a 2.6 weekly interval (78.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 4 times with a 7.8 weekly interval (31.2 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 281.6, "avg_administrations": 23}, {"drug": "NATALIZUMAB", "avg_dose_mg": 283.4, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £14,291
first_seen: 2021-08-18
last_seen: 2025-05-12
first_seen_parent: 2018-03-06
last_seen_parent: 2025-03-26
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 385.2, "avg_administrations": 6}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 20 times with a 8.3 weekly interval (166.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £4,765
first_seen: 2021-07-24
last_seen: 2025-06-19
first_seen_parent: 2020-08-17
last_seen_parent: 2025-02-10
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 229.8, "avg_administrations": 20}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 12 times with a 7.5 weekly interval (90.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £4,955
first_seen: 2020-02-14
last_seen: 2024-04-01
first_seen_parent: 2018-01-16
last_seen_parent: 2025-05-26
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 352.2, "avg_administrations": 29}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 24 times with a 3.4 weekly interval (81.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £24,351
first_seen: 2020-01-14
last_seen: 2024-05-15
first_seen_parent: 2017-12-05
last_seen_parent: 2025-03-12
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 209.8, "avg_administrations": 9}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 11.2 weekly interval (67.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,490
first_seen: 2019-03-22
last_seen: 2024-12-23
first_seen_parent: 2018-01-29
last_seen_parent: 2024-07-26
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 306.4, "avg_administrations": 26}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 17 times with a 3.5 weekly interval (59.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD
ids: DEMO ICS - THORNBURY ROYAL INFIRMARY NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £3,621
first_seen: 2018-09-20
last_seen: 2024-06-10
first_seen_parent: 2019-10-31
last_seen_parent: 2025-06-12
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 165.1, "avg_administrations": 23}]
trust_name: THORNBURY ROYAL INFIRMARY NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 21 times with a 6.9 weekly interval (144.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £16,362
first_seen: 2019-07-08
last_seen: 2025-12-13
first_seen_parent: 2018-12-30
last_seen_parent: 2024-07-15
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 150.0, "avg_administrations": 6}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 28 times with a 6.1 weekly interval (170.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: BARICITINIB
cost_pp_pa: £10,846
first_seen: 2022-06-12
last_seen: 2024-12-14
first_seen_parent: 2021-09-20
last_seen_parent: 2025-04-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB - BARICITINIB

average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 11 times with a 10.6 weekly interval (116.6 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 10 times with a 2.9 weekly interval (29.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 266.1, "avg_administrations": 5}, {"drug": "BARICITINIB", "avg_dose_mg": 379.1, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £19,778
first_seen: 2021-02-03
last_seen: 2025-02-22
first_seen_parent: 2020-05-04
last_seen_parent: 2025-08-04
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 291.5, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 19 times with a 8.0 weekly interval (152.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £16,837
first_seen: 2020-05-14
last_seen: 2025-09-29
first_seen_parent: 2019-08-03
last_seen_parent: 2025-06-29
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 97.6, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 18 times with a 9.3 weekly interval (167.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £29,287
first_seen: 2020-10-22
last_seen: 2025-02-21
first_seen_parent: 2020-01-22
last_seen_parent: 2025-05-24
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 141.7, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 7 times with a 2.3 weekly interval (16.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £6,354
first_seen: 2022-05-16
last_seen: 2024-11-28
first_seen_parent: 2020-06-16
last_seen_parent: 2024-02-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 4.2 weekly interval (126.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 7 times with a 6.6 weekly interval (46.2 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 228.9, "avg_administrations": 11}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 106.8, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £17,151
first_seen: 2019-09-23
last_seen: 2025-10-20
first_seen_parent: 2021-07-28
last_seen_parent: 2024-06-25
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 10 times with a 6.1 weekly interval (61.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 5 times with a 2.4 weekly interval (12.0 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 204.8, "avg_administrations": 30}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 117.3, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £7,957
first_seen: 2021-06-16
last_seen: 2025-05-14
first_seen_parent: 2019-05-28
last_seen_parent: 2024-07-23
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 72.2, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 29 times with a 10.3 weekly interval (298.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £10,853
first_seen: 2022-12-04
last_seen: 2025-04-20
first_seen_parent: 2021-08-09
last_seen_parent: 2025-09-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10 times with a 2.0 weekly interval (20.0 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 19 times with a 8.0 weekly interval (152.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 429.7, "avg_administrations": 23}, {"drug": "RITUXIMAB", "avg_dose_mg": 54.0, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £27,695
first_seen: 2021-05-15
last_seen: 2025-05-25
first_seen_parent: 2017-08-14
last_seen_parent: 2024-06-28
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 75.6, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 15 times with a 9.0 weekly interval (135.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £17,783
first_seen: 2020-05-29
last_seen: 2024-02-05
first_seen_parent: 2018-11-06
last_seen_parent: 2025-11-24
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 428.7, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 8 times with a 5.0 weekly interval (40.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £3,594
first_seen: 2021-03-03
last_seen: 2024-12-05
first_seen_parent: 2018-06-27
last_seen_parent: 2025-01-10
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 22 times with a 11.0 weekly interval (242.0 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 10.2 weekly interval (224.4 weeks total treatment length)

average_administered:
[{"drug": "ADALIMUMAB", "avg_dose_mg": 165.3, "avg_administrations": 16}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 435.3, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £17,350
first_seen: 2021-01-18
last_seen: 2024-03-31
first_seen_parent: 2017-11-23
last_seen_parent: 2024-10-30
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 398.2, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 12 times with a 6.9 weekly interval (82.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £5,352
first_seen: 2020-02-07
last_seen: 2024-08-08
first_seen_parent: 2018-08-11
last_seen_parent: 2025-11-22
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 444.2, "avg_administrations": 26}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 15 times with a 8.3 weekly interval (124.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Crohn's disease - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,108
first_seen: 2020-12-03
last_seen: 2025-12-21
first_seen_parent: 2018-04-17
last_seen_parent: 2024-07-23
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 193.7, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 12 times with a 2.2 weekly interval (26.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: SECUKINUMAB
cost_pp_pa: £6,704
first_seen: 2022-10-23
last_seen: 2025-09-12
first_seen_parent: 2018-04-24
last_seen_parent: 2024-07-29
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT|SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT - SECUKINUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 30 times with a 5.1 weekly interval (153.0 weeks total treatment length)<br><b>SECUKINUMAB</b><br>On average given 21 times with a 3.2 weekly interval (67.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 295.5, "avg_administrations": 22}, {"drug": "SECUKINUMAB", "avg_dose_mg": 296.5, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: NIVOLUMAB
cost_pp_pa: £3,952
first_seen: 2022-06-22
last_seen: 2025-07-09
first_seen_parent: 2020-06-17
last_seen_parent: 2025-04-23
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT - NIVOLUMAB

average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 27 times with a 3.7 weekly interval (99.9 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 6 times with a 7.7 weekly interval (46.2 weeks total treatment length)

average_administered:
[{"drug": "AFLIBERCEPT", "avg_dose_mg": 463.7, "avg_administrations": 11}, {"drug": "NIVOLUMAB", "avg_dose_mg": 287.7, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,961
first_seen: 2018-12-30
last_seen: 2025-01-30
first_seen_parent: 2020-05-07
last_seen_parent: 2024-07-03
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 288.2, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 15 times with a 3.8 weekly interval (57.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £19,093
first_seen: 2021-08-23
last_seen: 2025-09-27
first_seen_parent: 2020-05-26
last_seen_parent: 2025-05-30
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 249.1, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 11 times with a 8.9 weekly interval (97.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £4,014
first_seen: 2019-05-05
last_seen: 2025-05-11
first_seen_parent: 2019-06-29
last_seen_parent: 2024-05-03
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 414.1, "avg_administrations": 16}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 14 times with a 3.5 weekly interval (49.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £14,870
first_seen: 2019-07-17
last_seen: 2024-08-21
first_seen_parent: 2018-08-29
last_seen_parent: 2025-02-19
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 479.1, "avg_administrations": 23}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 22 times with a 4.9 weekly interval (107.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £10,416
first_seen: 2019-10-09
last_seen: 2025-01-29
first_seen_parent: 2017-05-05
last_seen_parent: 2025-05-30
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 83.6, "avg_administrations": 27}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 29 times with a 4.5 weekly interval (130.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £11,399
first_seen: 2020-12-24
last_seen: 2024-03-18
first_seen_parent: 2019-10-11
last_seen_parent: 2024-03-27
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 472.7, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 21 times with a 3.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £20,388
first_seen: 2021-06-04
last_seen: 2024-06-11
first_seen_parent: 2017-10-23
last_seen_parent: 2025-10-18
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 338.0, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 13 times with a 5.1 weekly interval (66.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £9,218
first_seen: 2021-06-14
last_seen: 2024-03-13
first_seen_parent: 2021-10-14
last_seen_parent: 2025-02-11
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB|IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 11 times with a 3.2 weekly interval (35.2 weeks total treatment length)<br><b>IBRUTINIB</b><br>On average given 10 times with a 11.6 weekly interval (116.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 371.6, "avg_administrations": 24}, {"drug": "IBRUTINIB", "avg_dose_mg": 410.6, "avg_administrations": 7}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £3,741
first_seen: 2021-03-11
last_seen: 2025-01-01
first_seen_parent: 2021-05-26
last_seen_parent: 2024-08-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 10 times with a 6.7 weekly interval (67.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 10 times with a 7.7 weekly interval (77.0 weeks total treatment length)

average_administered:
[{"drug": "NATALIZUMAB", "avg_dose_mg": 239.4, "avg_administrations": 15}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 435.9, "avg_administrations": 30}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,148
first_seen: 2019-12-15
last_seen: 2024-10-15
first_seen_parent: 2020-04-22
last_seen_parent: 2025-05-14
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 198.8, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 20 times with a 5.1 weekly interval (102.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £11,102
first_seen: 2021-05-16
last_seen: 2024-11-03
first_seen_parent: 2019-01-01
last_seen_parent: 2025-04-02
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 327.9, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 14 times with a 2.6 weekly interval (36.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £25,535
first_seen: 2020-04-07
last_seen: 2024-03-02
first_seen_parent: 2017-07-01
last_seen_parent: 2025-03-07
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 228.7, "avg_administrations": 29}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 21 times with a 6.2 weekly interval (130.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: LENALIDOMIDE
cost_pp_pa: £16,317
first_seen: 2021-04-22
last_seen: 2025-07-04
first_seen_parent: 2021-02-08
last_seen_parent: 2025-12-09
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - LENALIDOMIDE

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 8 times with a 7.5 weekly interval (60.0 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 8 times with a 8.3 weekly interval (66.4 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 122.2, "avg_administrations": 9}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 310.3, "avg_administrations": 4}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,049
first_seen: 2019-01-10
last_seen: 2024-10-01
first_seen_parent: 2021-11-09
last_seen_parent: 2025-11-28
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB - BEVACIZUMAB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 6 times with a 7.1 weekly interval (42.6 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 27 times with a 4.0 weekly interval (108.0 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 62.9, "avg_administrations": 12}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 448.1, "avg_administrations": 12}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £16,465
first_seen: 2020-08-26
last_seen: 2024-04-20
first_seen_parent: 2019-08-20
last_seen_parent: 2025-03-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 272.9, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 8 times with a 7.7 weekly interval (61.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: NIVOLUMAB
cost_pp_pa: £3,969
first_seen: 2022-09-09
last_seen: 2025-12-20
first_seen_parent: 2019-12-18
last_seen_parent: 2025-08-31
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB - NIVOLUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 25 times with a 11.1 weekly interval (277.5 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 6 times with a 10.9 weekly interval (65.4 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 79.3, "avg_administrations": 27}, {"drug": "NIVOLUMAB", "avg_dose_mg": 288.6, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £12,517
first_seen: 2021-06-26
last_seen: 2025-01-06
first_seen_parent: 2017-01-25
last_seen_parent: 2024-08-04
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 52.1, "avg_administrations": 22}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 10 times with a 10.5 weekly interval (105.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £26,510
first_seen: 2021-11-29
last_seen: 2025-08-21
first_seen_parent: 2020-06-18
last_seen_parent: 2025-07-26
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 205.6, "avg_administrations": 17}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 27 times with a 10.8 weekly interval (291.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £7,649
first_seen: 2021-07-06
last_seen: 2024-04-08
first_seen_parent: 2018-02-28
last_seen_parent: 2025-03-28
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 440.6, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 22 times with a 11.7 weekly interval (257.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £8,186
first_seen: 2018-02-20
last_seen: 2024-05-29
first_seen_parent: 2018-06-21
last_seen_parent: 2025-06-03
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 150.4, "avg_administrations": 7}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 13 times with a 8.2 weekly interval (106.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £6,413
first_seen: 2020-06-23
last_seen: 2024-04-08
first_seen_parent: 2017-06-17
last_seen_parent: 2025-12-26
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 439.1, "avg_administrations": 21}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 9 times with a 7.0 weekly interval (63.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £8,844
first_seen: 2021-12-09
last_seen: 2025-02-24
first_seen_parent: 2017-09-06
last_seen_parent: 2025-04-21
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 215.9, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 10.0 weekly interval (260.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £9,561
first_seen: 2019-03-25
last_seen: 2024-11-26
first_seen_parent: 2021-09-23
last_seen_parent: 2024-11-16
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 17 times with a 3.2 weekly interval (54.4 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 5 times with a 9.7 weekly interval (48.5 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 263.4, "avg_administrations": 27}, {"drug": "ADALIMUMAB", "avg_dose_mg": 76.5, "avg_administrations": 4}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £11,159
first_seen: 2019-03-25
last_seen: 2025-02-03
first_seen_parent: 2021-03-26
last_seen_parent: 2024-03-19
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 5 times with a 3.1 weekly interval (15.5 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 7.9 weekly interval (71.1 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 407.6, "avg_administrations": 12}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 247.8, "avg_administrations": 8}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £14,470
first_seen: 2021-07-23
last_seen: 2025-01-27
first_seen_parent: 2019-01-22
last_seen_parent: 2025-10-04
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 267.4, "avg_administrations": 5}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 12 times with a 9.2 weekly interval (110.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £19,770
first_seen: 2020-04-06
last_seen: 2025-01-21
first_seen_parent: 2019-11-20
last_seen_parent: 2025-03-07
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 10 times with a 3.0 weekly interval (30.0 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 17 times with a 10.0 weekly interval (170.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 305.3, "avg_administrations": 21}, {"drug": "BARICITINIB", "avg_dose_mg": 223.7, "avg_administrations": 30}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £17,803
first_seen: 2021-02-28
last_seen: 2024-08-17
first_seen_parent: 2019-04-03
last_seen_parent: 2025-08-28
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 14 times with a 5.4 weekly interval (75.6 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 2.3 weekly interval (52.9 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 220.6, "avg_administrations": 24}, {"drug": "NATALIZUMAB", "avg_dose_mg": 244.1, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £15,507
first_seen: 2020-09-18
last_seen: 2025-04-29
first_seen_parent: 2019-08-26
last_seen_parent: 2024-08-04
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 281.4, "avg_administrations": 10}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 9 times with a 10.4 weekly interval (93.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,091
first_seen: 2020-08-19
last_seen: 2024-04-15
first_seen_parent: 2017-03-03
last_seen_parent: 2025-11-10
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 378.8, "avg_administrations": 8}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 4.7 weekly interval (32.9 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £11,641
first_seen: 2019-02-02
last_seen: 2024-12-05
first_seen_parent: 2021-12-20
last_seen_parent: 2024-08-05
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 2.4 weekly interval (38.4 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 19 times with a 5.0 weekly interval (95.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 77.9, "avg_administrations": 8}, {"drug": "NATALIZUMAB", "avg_dose_mg": 409.9, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £10,580
first_seen: 2022-04-25
last_seen: 2025-05-05
first_seen_parent: 2021-01-24
last_seen_parent: 2024-06-01
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB|PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 16 times with a 8.4 weekly interval (134.4 weeks total treatment length)<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 9.0 weekly interval (126.0 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 447.6, "avg_administrations": 22}, {"drug": "PEMBROLIZUMAB", "avg_dose_mg": 231.2, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £9,290
first_seen: 2019-09-13
last_seen: 2025-03-17
first_seen_parent: 2019-01-07
last_seen_parent: 2025-07-30
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 455.2, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 19 times with a 11.9 weekly interval (226.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £7,078
first_seen: 2021-08-10
last_seen: 2025-10-29
first_seen_parent: 2018-01-20
last_seen_parent: 2025-01-09
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 411.6, "avg_administrations": 4}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 6 times with a 5.7 weekly interval (34.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £3,952
first_seen: 2019-04-19
last_seen: 2025-01-04
first_seen_parent: 2018-05-21
last_seen_parent: 2025-02-02
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 15 times with a 8.2 weekly interval (123.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 5.2 weekly interval (41.6 weeks total treatment length)

average_administered:
[{"drug": "BARICITINIB", "avg_dose_mg": 112.9, "avg_administrations": 17}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 488.4, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £18,485
first_seen: 2020-05-28
last_seen: 2024-03-15
first_seen_parent: 2017-12-13
last_seen_parent: 2024-01-27
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 289.2, "avg_administrations": 24}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 11 times with a 9.2 weekly interval (101.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £18,159
first_seen: 2021-06-09
last_seen: 2025-02-05
first_seen_parent: 2018-11-20
last_seen_parent: 2024-03-12
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 450.6, "avg_administrations": 11}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 18 times with a 2.4 weekly interval (43.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £19,725
first_seen: 2021-07-26
last_seen: 2025-08-08
first_seen_parent: 2020-06-28
last_seen_parent: 2025-09-19
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 473.5, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 21 times with a 6.0 weekly interval (126.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £19,378
first_seen: 2019-12-28
last_seen: 2025-05-12
first_seen_parent: 2021-07-10
last_seen_parent: 2025-08-22
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 3.2 weekly interval (92.8 weeks total treatment length)<br><b>RITUXIMAB</b><br>On average given 26 times with a 10.0 weekly interval (260.0 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 167.2, "avg_administrations": 22}, {"drug": "RITUXIMAB", "avg_dose_mg": 257.9, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £11,883
first_seen: 2022-11-17
last_seen: 2025-05-26
first_seen_parent: 2019-11-05
last_seen_parent: 2024-01-11
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 29 times with a 11.1 weekly interval (321.9 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 8 times with a 2.8 weekly interval (22.4 weeks total treatment length)

average_administered:
[{"drug": "TOFACITINIB", "avg_dose_mg": 77.4, "avg_administrations": 16}, {"drug": "NIVOLUMAB", "avg_dose_mg": 111.5, "avg_administrations": 13}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £20,411
first_seen: 2021-07-18
last_seen: 2025-05-12
first_seen_parent: 2018-08-28
last_seen_parent: 2025-01-13
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 144.9, "avg_administrations": 15}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 6 times with a 5.7 weekly interval (34.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £19,426
first_seen: 2018-08-10
last_seen: 2025-02-17
first_seen_parent: 2017-06-21
last_seen_parent: 2024-11-04
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 201.1, "avg_administrations": 12}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 7.8 weekly interval (140.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £18,217
first_seen: 2020-10-16
last_seen: 2025-12-16
first_seen_parent: 2020-02-25
last_seen_parent: 2024-04-26
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 218.7, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 6 times with a 5.3 weekly interval (31.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £16,083
first_seen: 2022-05-22
last_seen: 2025-01-24
first_seen_parent: 2021-06-11
last_seen_parent: 2024-10-03
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 10.3 weekly interval (61.8 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 28 times with a 8.8 weekly interval (246.4 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 462.7, "avg_administrations": 11}, {"drug": "INFLIXIMAB", "avg_dose_mg": 208.1, "avg_administrations": 18}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD
ids: DEMO ICS - ASHWORTH COMMUNITY HOSPITAL NHS TRUST - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £6,818
first_seen: 2020-12-25
last_seen: 2024-11-12
first_seen_parent: 2019-01-23
last_seen_parent: 2024-02-20
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 459.2, "avg_administrations": 18}]
trust_name: ASHWORTH COMMUNITY HOSPITAL NHS TRUST
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 23 times with a 10.6 weekly interval (243.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £11,323
first_seen: 2021-02-22
last_seen: 2025-02-01
first_seen_parent: 2017-12-04
last_seen_parent: 2025-06-03
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 227.0, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 8.2 weekly interval (221.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £10,006
first_seen: 2019-12-17
last_seen: 2025-01-09
first_seen_parent: 2020-10-23
last_seen_parent: 2024-11-30
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 11.5 weekly interval (287.5 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 30 times with a 11.1 weekly interval (333.0 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 199.1, "avg_administrations": 24}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 167.3, "avg_administrations": 29}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £16,382
first_seen: 2020-08-23
last_seen: 2025-07-19
first_seen_parent: 2021-01-31
last_seen_parent: 2025-01-26
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 6 times with a 10.5 weekly interval (63.0 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 23 times with a 10.7 weekly interval (246.1 weeks total treatment length)

average_administered:
[{"drug": "SECUKINUMAB", "avg_dose_mg": 367.3, "avg_administrations": 22}, {"drug": "NATALIZUMAB", "avg_dose_mg": 210.8, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ankylosing spondylitis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £18,594
first_seen: 2021-07-24
last_seen: 2025-07-23
first_seen_parent: 2017-12-15
last_seen_parent: 2025-09-07
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 437.8, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 26 times with a 11.6 weekly interval (301.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Atopic dermatitis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £14,828
first_seen: 2020-12-23
last_seen: 2025-03-13
first_seen_parent: 2020-05-29
last_seen_parent: 2025-10-30
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 223.4, "avg_administrations": 30}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 25 times with a 3.6 weekly interval (90.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £12,829
first_seen: 2020-11-03
last_seen: 2025-08-31
first_seen_parent: 2020-10-18
last_seen_parent: 2024-02-12
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 4.6 weekly interval (138.0 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 28 times with a 5.7 weekly interval (159.6 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 156.6, "avg_administrations": 16}, {"drug": "USTEKINUMAB", "avg_dose_mg": 345.8, "avg_administrations": 5}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,605
first_seen: 2022-01-29
last_seen: 2024-01-25
first_seen_parent: 2020-07-21
last_seen_parent: 2025-05-03
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 30 times with a 4.1 weekly interval (123.0 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 23 times with a 8.4 weekly interval (193.2 weeks total treatment length)

average_administered:
[{"drug": "RITUXIMAB", "avg_dose_mg": 185.3, "avg_administrations": 21}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 159.9, "avg_administrations": 15}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £5,922
first_seen: 2021-12-22
last_seen: 2024-11-05
first_seen_parent: 2019-12-19
last_seen_parent: 2024-07-27
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 415.9, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 5 times with a 9.1 weekly interval (45.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £21,328
first_seen: 2021-09-23
last_seen: 2024-02-13
first_seen_parent: 2018-10-16
last_seen_parent: 2024-12-15
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 8 times with a 4.0 weekly interval (32.0 weeks total treatment length)<br><b>TRASTUZUMAB</b><br>On average given 22 times with a 2.3 weekly interval (50.6 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 176.1, "avg_administrations": 26}, {"drug": "TRASTUZUMAB", "avg_dose_mg": 66.5, "avg_administrations": 26}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £22,143
first_seen: 2022-09-03
last_seen: 2024-09-18
first_seen_parent: 2020-11-27
last_seen_parent: 2025-09-11
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 29 times with a 10.6 weekly interval (307.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 13 times with a 9.6 weekly interval (124.8 weeks total treatment length)

average_administered:
[{"drug": "IBRUTINIB", "avg_dose_mg": 443.7, "avg_administrations": 4}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 92.5, "avg_administrations": 11}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - CLL - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £11,405
first_seen: 2019-11-18
last_seen: 2024-09-17
first_seen_parent: 2017-08-23
last_seen_parent: 2024-01-18
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 380.3, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 27 times with a 5.3 weekly interval (143.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Colorectal cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £19,057
first_seen: 2019-05-28
last_seen: 2025-01-25
first_seen_parent: 2020-03-21
last_seen_parent: 2025-02-10
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 94.4, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 20 times with a 4.6 weekly interval (92.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £5,654
first_seen: 2021-08-22
last_seen: 2024-12-13
first_seen_parent: 2019-04-11
last_seen_parent: 2025-04-22
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 270.8, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 7 times with a 10.5 weekly interval (73.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £15,222
first_seen: 2021-10-10
last_seen: 2024-11-09
first_seen_parent: 2021-06-26
last_seen_parent: 2024-08-08
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 8 times with a 6.3 weekly interval (50.4 weeks total treatment length)<br><b>INFLIXIMAB</b><br>On average given 12 times with a 7.5 weekly interval (90.0 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 278.6, "avg_administrations": 22}, {"drug": "INFLIXIMAB", "avg_dose_mg": 240.1, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £15,951
first_seen: 2020-08-15
last_seen: 2024-02-10
first_seen_parent: 2020-12-02
last_seen_parent: 2024-10-01
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 23 times with a 6.8 weekly interval (156.4 weeks total treatment length)<br><b>USTEKINUMAB</b><br>On average given 18 times with a 6.1 weekly interval (109.8 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 301.0, "avg_administrations": 4}, {"drug": "USTEKINUMAB", "avg_dose_mg": 258.0, "avg_administrations": 30}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Crohn's disease - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £18,654
first_seen: 2018-12-12
last_seen: 2024-01-26
first_seen_parent: 2017-02-23
last_seen_parent: 2025-03-27
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 401.5, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 17 times with a 3.4 weekly interval (57.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Diabetic macular oedema - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £16,661
first_seen: 2020-11-16
last_seen: 2025-05-17
first_seen_parent: 2018-05-23
last_seen_parent: 2025-06-04
average_administered: [{"drug": "AFLIBERCEPT", "avg_dose_mg": 75.3, "avg_administrations": 13}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>AFLIBERCEPT</b><br>On average given 5 times with a 11.6 weekly interval (58.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £7,922
first_seen: 2021-02-22
last_seen: 2024-03-13
first_seen_parent: 2018-08-13
last_seen_parent: 2024-02-09
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 6.9 weekly interval (62.1 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 28 times with a 6.0 weekly interval (168.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 218.1, "avg_administrations": 8}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 102.8, "avg_administrations": 17}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,680
first_seen: 2020-08-08
last_seen: 2025-03-02
first_seen_parent: 2021-04-28
last_seen_parent: 2024-01-28
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB|ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 15 times with a 6.6 weekly interval (99.0 weeks total treatment length)<br><b>ADALIMUMAB</b><br>On average given 14 times with a 5.0 weekly interval (70.0 weeks total treatment length)

average_administered:
[{"drug": "TOCILIZUMAB", "avg_dose_mg": 171.4, "avg_administrations": 17}, {"drug": "ADALIMUMAB", "avg_dose_mg": 61.2, "avg_administrations": 21}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Giant cell arteritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £5,901
first_seen: 2018-09-30
last_seen: 2025-04-28
first_seen_parent: 2017-07-20
last_seen_parent: 2025-06-21
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 448.9, "avg_administrations": 23}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 9 times with a 5.3 weekly interval (47.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - HER2+ breast cancer - TRASTUZUMAB
labels: TRASTUZUMAB
cost_pp_pa: £22,260
first_seen: 2018-07-24
last_seen: 2024-06-09
first_seen_parent: 2017-06-06
last_seen_parent: 2024-11-05
average_administered: [{"drug": "TRASTUZUMAB", "avg_dose_mg": 111.7, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TRASTUZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TRASTUZUMAB</b><br>On average given 17 times with a 2.1 weekly interval (35.7 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Mantle cell lymphoma - IBRUTINIB
labels: IBRUTINIB
cost_pp_pa: £17,261
first_seen: 2020-03-24
last_seen: 2025-12-10
first_seen_parent: 2019-11-01
last_seen_parent: 2024-02-24
average_administered: [{"drug": "IBRUTINIB", "avg_dose_mg": 434.5, "avg_administrations": 19}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: IBRUTINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>IBRUTINIB</b><br>On average given 30 times with a 8.8 weekly interval (264.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £14,340
first_seen: 2020-08-02
last_seen: 2024-11-02
first_seen_parent: 2019-07-09
last_seen_parent: 2024-04-01
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 10 times with a 6.4 weekly interval (64.0 weeks total treatment length)<br><b>ETANERCEPT</b><br>On average given 16 times with a 4.2 weekly interval (67.2 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 400.2, "avg_administrations": 23}, {"drug": "ETANERCEPT", "avg_dose_mg": 186.2, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £5,933
first_seen: 2021-07-12
last_seen: 2025-01-17
first_seen_parent: 2019-07-13
last_seen_parent: 2025-01-05
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 7 times with a 3.7 weekly interval (25.9 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 18 times with a 2.3 weekly interval (41.4 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 270.1, "avg_administrations": 19}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 186.6, "avg_administrations": 9}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Melanoma - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £21,609
first_seen: 2020-12-24
last_seen: 2024-09-16
first_seen_parent: 2019-01-02
last_seen_parent: 2025-11-02
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 496.2, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 28 times with a 5.4 weekly interval (151.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £16,360
first_seen: 2019-12-19
last_seen: 2024-06-16
first_seen_parent: 2019-12-06
last_seen_parent: 2025-12-20
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE|RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 24 times with a 8.1 weekly interval (194.4 weeks total treatment length)<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 8.7 weekly interval (52.2 weeks total treatment length)

average_administered:
[{"drug": "LENALIDOMIDE", "avg_dose_mg": 465.0, "avg_administrations": 8}, {"drug": "RANIBIZUMAB", "avg_dose_mg": 185.6, "avg_administrations": 4}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple myeloma - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £23,676
first_seen: 2020-06-24
last_seen: 2024-05-24
first_seen_parent: 2018-12-08
last_seen_parent: 2024-09-02
average_administered: [{"drug": "LENALIDOMIDE", "avg_dose_mg": 208.0, "avg_administrations": 22}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>LENALIDOMIDE</b><br>On average given 9 times with a 6.0 weekly interval (54.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £14,403
first_seen: 2018-03-11
last_seen: 2024-06-09
first_seen_parent: 2017-04-19
last_seen_parent: 2024-08-02
average_administered: [{"drug": "OCRELIZUMAB", "avg_dose_mg": 230.6, "avg_administrations": 10}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>OCRELIZUMAB</b><br>On average given 18 times with a 8.0 weekly interval (144.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Multiple sclerosis - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £18,673
first_seen: 2021-07-11
last_seen: 2024-01-01
first_seen_parent: 2017-04-16
last_seen_parent: 2024-06-10
average_administered: [{"drug": "NATALIZUMAB", "avg_dose_mg": 208.8, "avg_administrations": 11}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NATALIZUMAB</b><br>On average given 9 times with a 5.9 weekly interval (53.1 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-Hodgkin lymphoma - RITUXIMAB
labels: RITUXIMAB
cost_pp_pa: £22,123
first_seen: 2020-03-06
last_seen: 2025-06-30
first_seen_parent: 2019-03-11
last_seen_parent: 2024-08-11
average_administered: [{"drug": "RITUXIMAB", "avg_dose_mg": 313.5, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RITUXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RITUXIMAB</b><br>On average given 21 times with a 6.3 weekly interval (132.3 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: BARICITINIB
cost_pp_pa: £10,312
first_seen: 2019-08-12
last_seen: 2024-01-25
first_seen_parent: 2020-03-17
last_seen_parent: 2025-05-13
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB - BARICITINIB

average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 14 times with a 11.1 weekly interval (155.4 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 5 times with a 4.9 weekly interval (24.5 weeks total treatment length)

average_administered:
[{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 420.8, "avg_administrations": 22}, {"drug": "BARICITINIB", "avg_dose_mg": 437.1, "avg_administrations": 21}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - PEMBROLIZUMAB
labels: PEMBROLIZUMAB
cost_pp_pa: £5,842
first_seen: 2021-07-19
last_seen: 2024-05-28
first_seen_parent: 2018-09-23
last_seen_parent: 2025-04-15
average_administered: [{"drug": "PEMBROLIZUMAB", "avg_dose_mg": 302.0, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: PEMBROLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>PEMBROLIZUMAB</b><br>On average given 15 times with a 4.0 weekly interval (60.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: BARICITINIB
cost_pp_pa: £4,999
first_seen: 2021-05-04
last_seen: 2024-03-28
first_seen_parent: 2018-01-26
last_seen_parent: 2024-06-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB|BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB - BARICITINIB

average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 11 times with a 5.3 weekly interval (58.3 weeks total treatment length)<br><b>BARICITINIB</b><br>On average given 16 times with a 10.1 weekly interval (161.6 weeks total treatment length)

average_administered:
[{"drug": "NIVOLUMAB", "avg_dose_mg": 469.2, "avg_administrations": 13}, {"drug": "BARICITINIB", "avg_dose_mg": 149.4, "avg_administrations": 30}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £19,063
first_seen: 2021-01-10
last_seen: 2025-01-10
first_seen_parent: 2019-06-28
last_seen_parent: 2024-04-25
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 198.1, "avg_administrations": 24}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 21 times with a 4.2 weekly interval (88.2 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: NIVOLUMAB
cost_pp_pa: £18,034
first_seen: 2019-04-23
last_seen: 2024-03-06
first_seen_parent: 2020-11-26
last_seen_parent: 2024-08-23
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB - NIVOLUMAB

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 24 times with a 7.9 weekly interval (189.6 weeks total treatment length)<br><b>NIVOLUMAB</b><br>On average given 10 times with a 7.5 weekly interval (75.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 51.9, "avg_administrations": 28}, {"drug": "NIVOLUMAB", "avg_dose_mg": 241.4, "avg_administrations": 23}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: LENALIDOMIDE
cost_pp_pa: £5,714
first_seen: 2019-01-18
last_seen: 2024-11-30
first_seen_parent: 2021-08-18
last_seen_parent: 2025-04-17
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
ids:
DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB - LENALIDOMIDE

average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 13 times with a 7.7 weekly interval (100.1 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 15 times with a 4.2 weekly interval (63.0 weeks total treatment length)

average_administered:
[{"drug": "BEVACIZUMAB", "avg_dose_mg": 233.5, "avg_administrations": 7}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 194.5, "avg_administrations": 6}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Non-small cell lung cancer - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £10,164
first_seen: 2020-05-14
last_seen: 2025-02-20
first_seen_parent: 2019-05-01
last_seen_parent: 2025-10-17
average_administered: [{"drug": "BEVACIZUMAB", "avg_dose_mg": 228.5, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 8.4 weekly interval (184.8 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £8,705
first_seen: 2020-07-29
last_seen: 2024-01-06
first_seen_parent: 2018-06-02
last_seen_parent: 2024-04-01
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 159.3, "avg_administrations": 28}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 18 times with a 5.2 weekly interval (93.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £6,556
first_seen: 2021-07-30
last_seen: 2024-01-04
first_seen_parent: 2019-08-22
last_seen_parent: 2024-09-07
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 421.2, "avg_administrations": 17}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 10 times with a 10.0 weekly interval (100.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB - LENALIDOMIDE
labels: LENALIDOMIDE
cost_pp_pa: £10,227
first_seen: 2022-11-26
last_seen: 2025-02-23
first_seen_parent: 2021-03-18
last_seen_parent: 2025-08-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB|LENALIDOMIDE
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 23 times with a 5.2 weekly interval (119.6 weeks total treatment length)<br><b>LENALIDOMIDE</b><br>On average given 13 times with a 6.6 weekly interval (85.8 weeks total treatment length)

average_administered:
[{"drug": "USTEKINUMAB", "avg_dose_mg": 493.3, "avg_administrations": 12}, {"drug": "LENALIDOMIDE", "avg_dose_mg": 414.0, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriasis - USTEKINUMAB
labels: USTEKINUMAB
cost_pp_pa: £11,128
first_seen: 2021-10-30
last_seen: 2024-09-18
first_seen_parent: 2017-03-26
last_seen_parent: 2024-02-04
average_administered: [{"drug": "USTEKINUMAB", "avg_dose_mg": 358.0, "avg_administrations": 4}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: USTEKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>USTEKINUMAB</b><br>On average given 4 times with a 7.6 weekly interval (30.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT - NATALIZUMAB
labels: NATALIZUMAB
cost_pp_pa: £12,420
first_seen: 2019-08-15
last_seen: 2024-12-19
first_seen_parent: 2020-07-03
last_seen_parent: 2025-06-14
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT|NATALIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 2.6 weekly interval (70.2 weeks total treatment length)<br><b>NATALIZUMAB</b><br>On average given 26 times with a 9.2 weekly interval (239.2 weeks total treatment length)

average_administered:
[{"drug": "ETANERCEPT", "avg_dose_mg": 264.8, "avg_administrations": 15}, {"drug": "NATALIZUMAB", "avg_dose_mg": 250.5, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - ETANERCEPT
labels: ETANERCEPT
cost_pp_pa: £17,622
first_seen: 2020-11-25
last_seen: 2025-12-11
first_seen_parent: 2019-12-23
last_seen_parent: 2025-06-13
average_administered: [{"drug": "ETANERCEPT", "avg_dose_mg": 458.0, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ETANERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ETANERCEPT</b><br>On average given 27 times with a 12.0 weekly interval (324.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Psoriatic arthritis - SECUKINUMAB
labels: SECUKINUMAB
cost_pp_pa: £3,693
first_seen: 2018-01-22
last_seen: 2024-11-28
first_seen_parent: 2020-07-03
last_seen_parent: 2024-09-17
average_administered: [{"drug": "SECUKINUMAB", "avg_dose_mg": 390.3, "avg_administrations": 18}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: SECUKINUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>SECUKINUMAB</b><br>On average given 25 times with a 4.4 weekly interval (110.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Renal cell carcinoma - NIVOLUMAB
labels: NIVOLUMAB
cost_pp_pa: £23,071
first_seen: 2020-05-05
last_seen: 2025-01-27
first_seen_parent: 2017-04-15
last_seen_parent: 2024-11-26
average_administered: [{"drug": "NIVOLUMAB", "avg_dose_mg": 495.5, "avg_administrations": 6}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: NIVOLUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>NIVOLUMAB</b><br>On average given 13 times with a 2.8 weekly interval (36.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - BARICITINIB
labels: BARICITINIB
cost_pp_pa: £17,877
first_seen: 2018-08-09
last_seen: 2025-01-22
first_seen_parent: 2018-05-20
last_seen_parent: 2024-10-11
average_administered: [{"drug": "BARICITINIB", "avg_dose_mg": 249.7, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: BARICITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>BARICITINIB</b><br>On average given 13 times with a 3.2 weekly interval (41.6 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Rheumatoid arthritis - TOCILIZUMAB
labels: TOCILIZUMAB
cost_pp_pa: £25,416
first_seen: 2020-05-26
last_seen: 2025-02-15
first_seen_parent: 2017-05-07
last_seen_parent: 2024-01-04
average_administered: [{"drug": "TOCILIZUMAB", "avg_dose_mg": 169.2, "avg_administrations": 15}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOCILIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOCILIZUMAB</b><br>On average given 15 times with a 10.0 weekly interval (150.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - INFLIXIMAB
labels: INFLIXIMAB
cost_pp_pa: £15,374
first_seen: 2018-04-13
last_seen: 2024-03-16
first_seen_parent: 2017-08-19
last_seen_parent: 2025-09-11
average_administered: [{"drug": "INFLIXIMAB", "avg_dose_mg": 242.8, "avg_administrations": 16}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: INFLIXIMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>INFLIXIMAB</b><br>On average given 5 times with a 2.7 weekly interval (13.5 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - AFLIBERCEPT
labels: AFLIBERCEPT
cost_pp_pa: £6,811
first_seen: 2021-05-30
last_seen: 2025-12-17
first_seen_parent: 2020-12-15
last_seen_parent: 2024-04-19
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|AFLIBERCEPT
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 11 times with a 7.8 weekly interval (85.8 weeks total treatment length)<br><b>AFLIBERCEPT</b><br>On average given 22 times with a 8.6 weekly interval (189.2 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 389.3, "avg_administrations": 18}, {"drug": "AFLIBERCEPT", "avg_dose_mg": 320.4, "avg_administrations": 14}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB - BEVACIZUMAB
labels: BEVACIZUMAB
cost_pp_pa: £16,953
first_seen: 2020-06-20
last_seen: 2024-09-02
first_seen_parent: 2021-07-06
last_seen_parent: 2024-07-08
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB|BEVACIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 27 times with a 9.4 weekly interval (253.8 weeks total treatment length)<br><b>BEVACIZUMAB</b><br>On average given 22 times with a 9.3 weekly interval (204.6 weeks total treatment length)

average_administered:
[{"drug": "VEDOLIZUMAB", "avg_dose_mg": 203.7, "avg_administrations": 17}, {"drug": "BEVACIZUMAB", "avg_dose_mg": 276.2, "avg_administrations": 20}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £14,776
first_seen: 2020-07-08
last_seen: 2024-05-13
first_seen_parent: 2017-10-01
last_seen_parent: 2025-08-18
average_administered: [{"drug": "VEDOLIZUMAB", "avg_dose_mg": 127.6, "avg_administrations": 25}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>VEDOLIZUMAB</b><br>On average given 26 times with a 10.5 weekly interval (273.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Ulcerative colitis - TOFACITINIB
labels: TOFACITINIB
cost_pp_pa: £18,042
first_seen: 2019-04-08
last_seen: 2024-09-25
first_seen_parent: 2019-03-05
last_seen_parent: 2025-12-22
average_administered: [{"drug": "TOFACITINIB", "avg_dose_mg": 462.0, "avg_administrations": 26}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: TOFACITINIB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>TOFACITINIB</b><br>On average given 5 times with a 8.6 weekly interval (43.0 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Uveitis - ADALIMUMAB
labels: ADALIMUMAB
cost_pp_pa: £4,051
first_seen: 2019-05-17
last_seen: 2025-11-18
first_seen_parent: 2019-11-16
last_seen_parent: 2024-03-02
average_administered: [{"drug": "ADALIMUMAB", "avg_dose_mg": 376.5, "avg_administrations": 21}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: ADALIMUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>ADALIMUMAB</b><br>On average given 29 times with a 8.6 weekly interval (249.4 weeks total treatment length)


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - OCRELIZUMAB
labels: OCRELIZUMAB
cost_pp_pa: £5,734
first_seen: 2020-05-04
last_seen: 2025-07-27
first_seen_parent: 2020-09-16
last_seen_parent: 2024-05-02
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|OCRELIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 30 times with a 11.4 weekly interval (342.0 weeks total treatment length)<br><b>OCRELIZUMAB</b><br>On average given 4 times with a 11.7 weekly interval (46.8 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 246.2, "avg_administrations": 23}, {"drug": "OCRELIZUMAB", "avg_dose_mg": 449.7, "avg_administrations": 25}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB - VEDOLIZUMAB
labels: VEDOLIZUMAB
cost_pp_pa: £7,918
first_seen: 2022-02-22
last_seen: 2025-11-05
first_seen_parent: 2020-04-23
last_seen_parent: 2024-01-10
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB|VEDOLIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 6 times with a 7.9 weekly interval (47.4 weeks total treatment length)<br><b>VEDOLIZUMAB</b><br>On average given 9 times with a 2.2 weekly interval (19.8 weeks total treatment length)

average_administered:
[{"drug": "RANIBIZUMAB", "avg_dose_mg": 55.3, "avg_administrations": 21}, {"drug": "VEDOLIZUMAB", "avg_dose_mg": 453.6, "avg_administrations": 26}]


date_filter_id: 2yr_12mo
chart_type: indication
parents: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD
ids: DEMO ICS - KINGSBURY TEACHING HOSPITALS NHS FT - Wet AMD - RANIBIZUMAB
labels: RANIBIZUMAB
cost_pp_pa: £22,466
first_seen: 2018-04-20
last_seen: 2024-01-06
first_seen_parent: 2020-02-13
last_seen_parent: 2024-08-26
average_administered: [{"drug": "RANIBIZUMAB", "avg_dose_mg": 340.9, "avg_administrations": 9}]
trust_name: KINGSBURY TEACHING HOSPITALS NHS FT
drug_sequence: RANIBIZUMAB
created_at: 2026-02-17 11:12:14
data_refresh_id: 9df037f2-428a-44a8-a82f-78e26c41a562
average_spacing:
<br><b>RANIBIZUMAB</b><br>On average given 19 times with a 10.8 weekly interval (205.2 weeks total treatment length)


